CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | anthracenes |
|
Accession: | CHEBI:46955
|
browse the term
|
Definition: | Compounds containing an anthracene skeleton. |
Synonyms: | xref_mesh: | MESH:D000873 |
|
|
|
G |
Ar |
androgen receptor |
multiple interactions |
EXP |
Anthracenes analog inhibits the reaction [Metribolone binds to AR protein] |
CTD |
PMID:3695475 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Gabra1 |
gamma-aminobutyric acid type A receptor subunit alpha 1 |
multiple interactions decreases response to substance |
EXP |
Anthracenes analog promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] GABRA1 protein mutant form results in decreased susceptibility to Anthracenes analog |
CTD |
PMID:18275132 |
|
NCBI chr10:26,595,151...26,650,611
Ensembl chr10:26,595,160...26,650,864
|
|
G |
Gabrb2 |
gamma-aminobutyric acid type A receptor subunit beta 2 |
multiple interactions |
EXP |
Anthracenes analog promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] |
CTD |
PMID:18275132 |
|
NCBI chr10:26,936,592...27,156,141
Ensembl chr10:26,936,551...27,151,251
|
|
G |
Gabrg2 |
gamma-aminobutyric acid type A receptor subunit gamma 2 |
multiple interactions |
EXP |
Anthracenes analog promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] |
CTD |
PMID:18275132 |
|
NCBI chr10:26,374,693...26,463,937
Ensembl chr10:26,374,694...26,464,346
|
|
G |
Top1 |
DNA topoisomerase I |
decreases activity |
ISO |
Anthracenes results in decreased activity of TOP1 protein |
CTD |
PMID:7598737 |
|
NCBI chr 3:149,293,469...149,376,618
Ensembl chr 3:149,293,403...149,376,623
|
|
G |
Top2a |
DNA topoisomerase II alpha |
decreases activity |
ISO |
Anthracenes results in decreased activity of TOP2A protein |
CTD |
PMID:20561793 |
|
NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874
|
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions |
ISO |
1-amino-2,4-dibromoanthraquinone binds to and results in increased activity of ESR1 protein |
CTD |
PMID:20707409 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
increases mutagenesis |
ISO |
1-amino-2,4-dibromoanthraquinone results in increased mutagenesis of HRAS gene |
CTD |
PMID:11560247 |
|
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
increases activity |
ISO |
1-amino-2,4-dibromoanthraquinone results in increased activity of NFE2L2 protein |
CTD |
PMID:30203046 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
increases activity |
ISO |
1-amino-2,4-dibromoanthraquinone results in increased activity of NR1I3 protein |
CTD |
PMID:30203046 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
|
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
decreases activity |
ISO |
1-hydroxyanthraquinone results in decreased activity of CYP1A2 protein |
CTD |
PMID:33438235 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions |
ISO |
2-aminoanthraquinone binds to and results in increased activity of ESR1 protein |
CTD |
PMID:20707409 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases chemical synthesis multiple interactions |
ISO |
CYP1A2 protein results in increased chemical synthesis of 2-hydroxychrysophanol [CYP1A2 protein results in increased metabolism of chrysophanic acid] which results in increased chemical synthesis of 2-hydroxychrysophanol |
CTD |
PMID:29698620 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions increases chemical synthesis |
ISO |
[CYP3A4 protein results in increased metabolism of chrysophanic acid] which results in increased chemical synthesis of 2-hydroxychrysophanol CYP3A4 protein results in increased chemical synthesis of 2-hydroxychrysophanol |
CTD |
PMID:29698620 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
|
G |
Alb |
albumin |
affects binding |
ISO |
Alizarin Red S binds to ALB protein |
CTD |
PMID:18968587 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
ISO |
9,10-anthraquinone analog results in decreased expression of and results in decreased phosphorylation of AKT1 protein |
CTD |
PMID:26915975 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Bad |
BCL2-associated agonist of cell death |
increases expression |
ISO |
9,10-anthraquinone analog results in increased expression of BAD protein |
CTD |
PMID:26915975 |
|
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression |
ISO |
9,10-anthraquinone analog results in increased expression of BAX mRNA; 9,10-anthraquinone analog results in increased expression of BAX protein |
CTD |
PMID:26915975 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression |
ISO |
9,10-anthraquinone analog results in decreased expression of BCL2 mRNA; 9,10-anthraquinone analog results in decreased expression of BCL2 protein |
CTD |
PMID:26915975 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
decreases expression |
ISO |
9,10-anthraquinone analog results in decreased expression of BCL2L1 protein |
CTD |
PMID:26915975 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
|
|
G |
Bcl2l11 |
Bcl2-like 11 |
increases expression |
ISO |
9,10-anthraquinone analog results in increased expression of BCL2L11 protein |
CTD |
PMID:26915975 |
|
NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
|
|
G |
Casp3 |
caspase 3 |
increases activity increases expression |
ISO |
9,10-anthraquinone analog results in increased activity of CASP3 protein 9,10-anthraquinone analog results in increased expression of CASP3 mRNA |
CTD |
PMID:26915975 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
increases activity |
ISO |
9,10-anthraquinone analog results in increased activity of CASP9 protein |
CTD |
PMID:26915975 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
increases expression |
ISO |
9,10-anthraquinone results in increased expression of CCL5 mRNA |
CTD |
PMID:23333790 |
|
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression |
ISO |
9,10-anthraquinone analog results in decreased expression of CCND1 protein |
CTD |
PMID:26915975 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccnd2 |
cyclin D2 |
decreases expression |
ISO |
9,10-anthraquinone analog results in decreased expression of CCND2 protein |
CTD |
PMID:26915975 |
|
NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
decreases expression |
ISO |
9,10-anthraquinone analog results in decreased expression of PTGS2 mRNA; 9,10-anthraquinone analog results in decreased expression of PTGS2 protein |
CTD |
PMID:26915975 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
|
G |
Alb |
albumin |
affects binding |
ISO |
9-anthroic acid binds to ALB protein |
CTD |
PMID:16404478 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Cftr |
CF transmembrane conductance regulator |
decreases activity increases activity |
ISO |
9-anthroic acid results in decreased activity of CFTR protein 9-anthroic acid results in increased activity of CFTR protein mutant form |
CTD |
PMID:15290302 |
|
NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756
|
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions |
ISO |
9-nitroanthracene binds to and results in increased activity of AHR protein |
CTD |
PMID:28186253 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
decreases activity multiple interactions |
ISO |
alizarin results in decreased activity of CYP1A1 protein alizarin affects the reaction [Benzo(a)pyrene affects the activity of CYP1A1 protein] |
CTD |
PMID:12379470 PMID:37515497 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
decreases activity |
ISO |
alizarin results in decreased activity of CYP1A2 protein |
CTD |
PMID:12379470 PMID:33438235 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
decreases activity |
ISO |
alizarin results in decreased activity of CYP1B1 protein |
CTD |
PMID:12379470 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
decreases activity |
ISO |
alizarin results in decreased activity of CYP2E1 protein |
CTD |
PMID:12379470 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions |
ISO |
alizarin binds to and results in increased activity of ESR1 protein |
CTD |
PMID:20707409 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
H2ax |
H2A.X variant histone |
multiple interactions |
ISO |
alizarin inhibits the reaction [Benzo(a)pyrene results in increased expression of H2AX protein] |
CTD |
PMID:37515497 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO EXP |
alizarin inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of MAPK1 protein]; alizarin inhibits the reaction [Indican results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:33421718 PMID:38670245 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO |
alizarin inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:33421718 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Muc5ac |
mucin 5AC, oligomeric mucus/gel-forming |
multiple interactions |
ISO |
alizarin inhibits the reaction [Benzo(a)pyrene results in increased expression of MUC5AC mRNA]; alizarin inhibits the reaction [Benzo(a)pyrene results in increased expression of MUC5AC protein] |
CTD |
PMID:33421718 |
|
NCBI chr 1:196,864,336...196,896,475
Ensembl chr 1:196,864,336...196,896,475
|
|
G |
Nat1 |
N-acetyltransferase 1 |
decreases activity |
ISO |
alizarin results in decreased activity of NAT1 protein |
CTD |
PMID:34783865 |
|
NCBI chr16:22,218,217...22,238,516
Ensembl chr16:22,208,194...22,238,520
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase family 1 member A1 |
increases glucuronidation |
ISO |
UGT1A1 protein results in increased glucuronidation of alizarin |
CTD |
PMID:14557274 |
|
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a9 |
UDP glucuronosyltransferase family 1 member A9 |
increases glucuronidation |
ISO |
UGT1A9 protein results in increased glucuronidation of alizarin |
CTD |
PMID:14557274 |
|
NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt2b15 |
UDP glucuronosyltransferase family 2 member B15 |
increases metabolic processing |
EXP |
UGT2B15 protein results in increased metabolism of alizarin |
CTD |
PMID:7574722 |
|
NCBI chr14:20,768,015...20,783,599
Ensembl chr14:20,768,015...20,783,589
|
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
multiple interactions |
ISO |
aloe emodin inhibits the reaction [1-Methyl-3-isobutylxanthine results in decreased expression of ADIPOQ mRNA] |
CTD |
PMID:22645054 |
|
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Akr1b10 |
aldo-keto reductase family 1 member B10 |
decreases activity |
ISO |
aloe emodin results in decreased activity of AKR1B10 protein |
CTD |
PMID:35065925 |
|
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
|
|
G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
decreases activity |
ISO |
aloe emodin results in decreased activity of AKR1C3 protein |
CTD |
PMID:35065925 |
|
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
|
|
G |
Atf3 |
activating transcription factor 3 |
increases expression |
ISO |
aloe emodin results in increased expression of ATF3 mRNA |
CTD |
PMID:22210228 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression |
ISO |
aloe emodin results in increased expression of BAX protein |
CTD |
PMID:19928967 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression |
ISO |
aloe emodin results in decreased expression of BCL2 mRNA; aloe emodin results in decreased expression of BCL2 protein |
CTD |
PMID:19928967 PMID:22210228 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Casp3 |
caspase 3 |
increases activity multiple interactions increases cleavage increases expression |
ISO |
aloe emodin results in increased activity of CASP3 protein [Fluorouracil co-treated with aloe emodin] affects the expression of CASP3; Fluorouracil promotes the reaction [aloe emodin results in increased expression of CASP3 protein modified form] aloe emodin results in increased cleavage of CASP3 protein |
CTD |
PMID:19928967 PMID:22210228 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
increases activity multiple interactions increases expression |
ISO |
aloe emodin results in increased activity of CASP8 protein [Fluorouracil co-treated with aloe emodin] affects the expression of CASP8; Fluorouracil promotes the reaction [aloe emodin results in increased expression of CASP8 protein modified form] |
CTD |
PMID:19928967 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
increases activity increases expression multiple interactions |
ISO |
aloe emodin results in increased activity of CASP9 protein aloe emodin results in increased expression of CASP9 protein modified form [Fluorouracil co-treated with aloe emodin] affects the expression of CASP9; Fluorouracil promotes the reaction [aloe emodin results in increased expression of CASP9 protein modified form] |
CTD |
PMID:19928967 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cbr1 |
carbonyl reductase 1 |
decreases activity |
ISO |
aloe emodin results in decreased activity of CBR1 protein |
CTD |
PMID:35065925 |
|
NCBI chr11:32,860,571...32,862,981
Ensembl chr11:32,908,950...32,911,393 Ensembl chr11:32,908,950...32,911,393 Ensembl chr11:32,908,950...32,911,393
|
|
G |
Cycs |
cytochrome c, somatic |
increases expression |
ISO |
aloe emodin results in increased expression of CYCS protein |
CTD |
PMID:19928967 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
decreases activity |
ISO |
aloe emodin results in decreased activity of CYP1A1 protein |
CTD |
PMID:27633141 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
decreases activity |
ISO |
aloe emodin results in decreased activity of CYP1A2 protein |
CTD |
PMID:27633141 PMID:33438235 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
decreases activity |
ISO |
aloe emodin results in decreased activity of CYP1B1 protein |
CTD |
PMID:27633141 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
multiple interactions increases chemical synthesis |
ISO |
[CYP2B6 protein results in increased metabolism of chrysophanic acid] which results in increased chemical synthesis of aloe emodin CYP2B6 protein results in increased chemical synthesis of aloe emodin |
CTD |
PMID:29698620 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2c6 |
cytochrome P450, family 2, subfamily C, polypeptide 6 |
decreases activity |
ISO |
aloe emodin results in decreased activity of CYP2C19 protein |
CTD |
PMID:33438235 |
|
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
increases chemical synthesis multiple interactions |
ISO |
CYP3A4 protein results in increased chemical synthesis of aloe emodin [CYP3A4 protein results in increased metabolism of chrysophanic acid] which results in increased chemical synthesis of aloe emodin |
CTD |
PMID:29698620 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression |
ISO |
aloe emodin results in increased expression of DDIT3 mRNA; aloe emodin results in increased expression of DDIT3 protein |
CTD |
PMID:22210228 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Eif2s1 |
eukaryotic translation initiation factor 2 subunit alpha |
increases phosphorylation |
ISO |
aloe emodin results in increased phosphorylation of EIF2S1 protein |
CTD |
PMID:22210228 |
|
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
|
|
G |
Fabp4 |
fatty acid binding protein 4 |
multiple interactions |
ISO |
aloe emodin inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased expression of FABP4 mRNA] |
CTD |
PMID:22645054 |
|
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
|
|
G |
Fadd |
Fas associated via death domain |
multiple interactions |
ISO |
aloe emodin results in increased expression of and affects the localization of FADD protein |
CTD |
PMID:19928967 |
|
NCBI chr 1:199,743,200...199,745,746
Ensembl chr 1:199,739,994...199,745,653
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression |
ISO |
aloe emodin results in increased expression of FAS protein |
CTD |
PMID:19928967 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Faslg |
Fas ligand |
increases expression |
ISO |
aloe emodin results in increased expression of FASLG protein |
CTD |
PMID:19928967 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
increases expression |
ISO |
aloe emodin results in increased expression of HSPA5 mRNA; aloe emodin results in increased expression of HSPA5 protein |
CTD |
PMID:22210228 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Lpl |
lipoprotein lipase |
multiple interactions |
ISO |
aloe emodin inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased expression of LPL mRNA] |
CTD |
PMID:22645054 |
|
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
|
|
G |
Nat1 |
N-acetyltransferase 1 |
multiple interactions decreases expression |
ISO |
aloe emodin results in decreased expression of and results in decreased activity of NAT1 protein aloe emodin results in decreased expression of NAT1 mRNA |
CTD |
PMID:16314733 |
|
NCBI chr16:22,218,217...22,238,516
Ensembl chr16:22,208,194...22,238,520
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
aloe emodin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of NOS2 mRNA] |
CTD |
PMID:19352036 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions |
ISO |
aloe emodin inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased expression of PPARG mRNA] |
CTD |
PMID:22645054 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
aloe emodin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PTGS2 mRNA] |
CTD |
PMID:19352036 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Retn |
resistin |
multiple interactions |
ISO |
aloe emodin inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased expression of RETN mRNA] |
CTD |
PMID:22645054 |
|
NCBI chr12:1,710,881...1,712,621
Ensembl chr12:1,710,881...1,712,620
|
|
G |
Sult1a1 |
sulfotransferase family 1A member 1 |
decreases activity |
ISO |
aloe emodin results in decreased activity of SULT1A1 protein |
CTD |
PMID:27633141 |
|
NCBI chr 1:181,272,022...181,276,750
Ensembl chr 1:181,272,023...181,275,562
|
|
G |
Sult1e1 |
sulfotransferase family 1E member 1 |
decreases activity |
ISO |
aloe emodin results in decreased activity of SULT1E1 protein |
CTD |
PMID:27633141 |
|
NCBI chr14:20,422,324...20,439,562
Ensembl chr14:20,422,324...20,439,275
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases expression |
ISO |
aloe emodin inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased expression of TNF mRNA] aloe emodin results in increased expression of TNF protein |
CTD |
PMID:19928967 PMID:22645054 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
increases expression |
ISO |
aloe emodin results in increased expression of TNFRSF1A protein |
CTD |
PMID:19928967 |
|
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
|
|
G |
Tnfrsf1b |
TNF receptor superfamily member 1B |
increases expression |
ISO |
aloe emodin results in increased expression of TNFRSF1B protein |
CTD |
PMID:19928967 |
|
NCBI chr 5:157,070,642...157,104,216
Ensembl chr 5:157,070,642...157,104,206
|
|
G |
Tp53 |
tumor protein p53 |
increases expression |
ISO |
aloe emodin results in increased expression of TP53 protein |
CTD |
PMID:19928967 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tradd |
TNFRSF1A-associated via death domain |
multiple interactions |
ISO |
aloe emodin results in increased expression of and affects the localization of TRADD protein |
CTD |
PMID:19928967 |
|
NCBI chr19:33,136,148...33,142,714
Ensembl chr19:33,136,138...33,142,638
|
|
G |
Ugt1a9 |
UDP glucuronosyltransferase family 1 member A9 |
increases glucuronidation |
ISO |
UGT1A9 protein results in increased glucuronidation of aloe emodin |
CTD |
PMID:24854283 |
|
NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Xbp1 |
X-box binding protein 1 |
increases splicing |
ISO |
aloe emodin results in increased splicing of XBP1 mRNA |
CTD |
PMID:22210228 |
|
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
|
|
|
G |
Adam8 |
ADAM metallopeptidase domain 8 |
increases expression |
EXP |
2-anthramine results in increased expression of ADAM8 mRNA |
CTD |
PMID:23038007 |
|
NCBI chr 1:194,776,559...194,789,330
Ensembl chr 1:194,770,060...194,788,801
|
|
G |
Aen |
apoptosis enhancing nuclease |
increases expression |
EXP |
2-anthramine results in increased expression of AEN mRNA |
CTD |
PMID:23038007 |
|
NCBI chr 1:132,815,094...132,824,522
Ensembl chr 1:132,815,142...132,824,523
|
|
G |
Alb |
albumin |
decreases expression |
EXP |
2-anthramine results in decreased expression of ALB protein |
CTD |
PMID:31714650 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
increases expression |
EXP |
2-anthramine results in increased expression of ALDH1A1 mRNA |
CTD |
PMID:23038007 |
|
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
|
|
G |
Anxa1 |
annexin A1 |
increases expression |
EXP |
2-anthramine results in increased expression of ANXA1 mRNA |
CTD |
PMID:23038007 |
|
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
|
|
G |
Ar |
androgen receptor |
multiple interactions |
ISO |
2-anthramine inhibits the reaction [Metribolone results in increased activity of AR protein] |
CTD |
PMID:18324785 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Atp6v1d |
ATPase H+ transporting V1 subunit D |
increases expression |
EXP |
2-anthramine results in increased expression of ATP6V1D mRNA |
CTD |
PMID:23038007 |
|
NCBI chr 6:97,656,725...97,672,295
Ensembl chr 6:97,656,576...97,672,303
|
|
G |
Car2 |
carbonic anhydrase 2 |
increases expression |
EXP |
2-anthramine results in increased expression of CAR2 mRNA |
CTD |
PMID:23038007 |
|
NCBI chr 2:86,741,625...86,756,766
Ensembl chr 2:86,741,626...86,756,818
|
|
G |
Ccng1 |
cyclin G1 |
increases expression |
EXP |
2-anthramine results in increased expression of CCNG1 mRNA |
CTD |
PMID:23038007 |
|
NCBI chr10:25,176,231...25,182,604
Ensembl chr10:25,176,234...25,181,641
|
|
G |
Cd46 |
CD46 molecule |
increases expression |
EXP |
2-anthramine results in increased expression of CD46 mRNA |
CTD |
PMID:23038007 |
|
NCBI chr13:106,575,586...106,606,325
Ensembl chr13:106,574,858...106,660,445
|
|
G |
Cd93 |
CD93 molecule |
increases expression |
EXP |
2-anthramine results in increased expression of CD93 mRNA |
CTD |
PMID:23038007 |
|
NCBI chr 3:135,891,859...135,898,378
Ensembl chr 3:135,891,859...135,898,378
|
|
G |
Cdh13 |
cadherin 13 |
increases expression |
EXP |
2-anthramine results in increased expression of CDH13 mRNA |
CTD |
PMID:23038007 |
|
NCBI chr19:46,349,562...47,387,462
Ensembl chr19:46,349,430...47,387,459
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression |
EXP |
2-anthramine results in increased expression of CDKN1A mRNA |
CTD |
PMID:23038007 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
increases expression |
EXP |
2-anthramine results in increased expression of CDKN1C mRNA |
CTD |
PMID:23038007 |
|
NCBI chr 1:198,655,394...198,658,097
Ensembl chr 1:198,655,407...198,658,048
|
|
G |
Cyb5a |
cytochrome b5 type A |
multiple interactions |
ISO |
CYB5A protein promotes the reaction [CYP1A2 protein results in increased activity of 2-anthramine] |
CTD |
PMID:15728263 |
|
NCBI chr18:78,213,067...78,245,677
Ensembl chr18:78,202,342...78,258,535 Ensembl chr18:78,202,342...78,258,535
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions affects metabolic processing increases activity |
ISO |
CYB5A protein promotes the reaction [CYP1A2 protein results in increased activity of 2-anthramine] CYP1A2 protein affects the metabolism of 2-anthramine |
CTD |
PMID:2655891 PMID:15728263 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp4a8 |
cytochrome P450, family 4, subfamily a, polypeptide 8 |
decreases expression |
EXP |
2-anthramine results in decreased expression of CYP4A8 mRNA |
CTD |
PMID:23038007 |
|
NCBI chr 5:128,702,130...128,733,476
Ensembl chr 5:128,702,131...128,733,476
|
|
G |
Dcn |
decorin |
increases expression |
EXP |
2-anthramine results in increased expression of DCN mRNA |
CTD |
PMID:23038007 |
|
NCBI chr 7:32,281,252...32,321,291
Ensembl chr 7:32,281,252...32,321,270
|
|
G |
Ddit4 |
DNA-damage-inducible transcript 4 |
increases expression |
EXP |
2-anthramine results in increased expression of DDIT4 mRNA |
CTD |
PMID:23038007 |
|
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
|
|
G |
Dmbt1 |
deleted in malignant brain tumors 1 |
increases expression |
EXP |
2-anthramine results in increased expression of DMBT1 mRNA |
CTD |
PMID:23038007 |
|
NCBI chr 1:185,617,469...185,696,476
Ensembl chr 1:185,617,294...185,696,478
|
|
G |
Dph3 |
diphthamide biosynthesis 3 |
increases expression |
EXP |
2-anthramine results in increased expression of DPH3 mRNA |
CTD |
PMID:23038007 |
|
NCBI chr16:7,288,295...7,293,734
Ensembl chr16:7,282,705...7,291,265
|
|
G |
Fabp1 |
fatty acid binding protein 1 |
increases expression |
EXP |
2-anthramine results in increased expression of FABP1 mRNA |
CTD |
PMID:31714650 |
|
NCBI chr 4:103,191,015...103,194,791
Ensembl chr 4:103,191,006...103,194,788
|
|
G |
Fabp4 |
fatty acid binding protein 4 |
increases expression |
EXP |
2-anthramine results in increased expression of FABP4 mRNA |
CTD |
PMID:23038007 |
|
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression |
EXP |
2-anthramine results in increased expression of FAS mRNA |
CTD |
PMID:23038007 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
G6pc1 |
glucose-6-phosphatase catalytic subunit 1 |
increases expression |
EXP |
2-anthramine results in increased expression of G6PC1 mRNA |
CTD |
PMID:23038007 |
|
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
|
|
G |
Gck |
glucokinase |
increases expression |
EXP |
2-anthramine results in increased expression of GCK mRNA |
CTD |
PMID:23038007 |
|
NCBI chr14:80,785,060...80,829,842
Ensembl chr14:80,785,060...80,826,995
|
|
G |
Gria3 |
glutamate ionotropic receptor AMPA type subunit 3 |
increases expression |
EXP |
2-anthramine results in increased expression of GRIA3 mRNA |
CTD |
PMID:23038007 |
|
NCBI chr X:120,238,515...120,504,106
Ensembl chr X:120,238,534...120,504,096
|
|
G |
Gsta5 |
glutathione S-transferase alpha 5 |
increases expression |
EXP |
2-anthramine results in increased expression of GSTA5 mRNA |
CTD |
PMID:23038007 |
|
NCBI chr 8:79,105,561...79,117,472
Ensembl chr 8:79,105,661...79,117,472
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
increases expression |
EXP |
2-anthramine results in increased expression of HAVCR1 mRNA |
CTD |
PMID:31714650 |
|
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
increases activity |
ISO |
2-anthramine results in increased activity of HIF1A protein |
CTD |
PMID:19502547 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
[2-anthramine co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IFNG mRNA |
CTD |
PMID:29594315 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Igfbp2 |
insulin-like growth factor binding protein 2 |
increases expression |
EXP |
2-anthramine results in increased expression of IGFBP2 mRNA |
CTD |
PMID:23038007 |
|
NCBI chr 9:74,415,574...74,442,945
Ensembl chr 9:74,415,546...74,442,937
|
|
G |
Il1b |
interleukin 1 beta |
decreases expression increases expression |
ISO EXP |
2-anthramine results in decreased expression of IL1B mRNA 2-anthramine results in increased expression of IL1B mRNA |
CTD |
PMID:29594315 PMID:31714650 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il2 |
interleukin 2 |
multiple interactions |
ISO |
[2-anthramine co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IL2 mRNA |
CTD |
PMID:29594315 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il7 |
interleukin 7 |
increases expression |
EXP |
2-anthramine results in increased expression of IL7 mRNA |
CTD |
PMID:31714650 |
|
NCBI chr 2:94,235,219...94,280,075
Ensembl chr 2:94,234,766...94,280,075
|
|
G |
Jam3 |
junctional adhesion molecule 3 |
increases expression |
EXP |
2-anthramine results in increased expression of JAM3 mRNA |
CTD |
PMID:23038007 |
|
NCBI chr 8:25,508,461...25,569,306
Ensembl chr 8:25,507,057...25,569,355
|
|
G |
Lama5 |
laminin subunit alpha 5 |
increases expression |
EXP |
2-anthramine results in increased expression of LAMA5 mRNA |
CTD |
PMID:23038007 |
|
NCBI chr 3:167,270,296...167,318,370
Ensembl chr 3:167,270,296...167,318,451
|
|
G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
increases expression |
EXP |
2-anthramine results in increased expression of MGMT mRNA |
CTD |
PMID:23038007 |
|
NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756
|
|
G |
Mmd2 |
monocyte to macrophage differentiation-associated 2 |
decreases expression |
EXP |
2-anthramine results in decreased expression of MMD2 mRNA |
CTD |
PMID:23038007 |
|
NCBI chr12:11,962,733...12,009,776
Ensembl chr12:11,962,757...12,009,773
|
|
G |
Nhej1 |
nonhomologous end-joining factor 1 |
increases expression |
EXP |
2-anthramine results in increased expression of NHEJ1 mRNA |
CTD |
PMID:23038007 |
|
NCBI chr 9:76,526,322...76,622,488
Ensembl chr 9:76,526,324...76,622,444
|
|
G |
Nrcam |
neuronal cell adhesion molecule |
increases expression |
EXP |
2-anthramine results in increased expression of NRCAM mRNA |
CTD |
PMID:23038007 |
|
NCBI chr 6:61,402,813...61,698,536
Ensembl chr 6:61,329,863...61,702,992
|
|
G |
Pln |
phospholamban |
increases expression |
EXP |
2-anthramine results in increased expression of PLN mRNA |
CTD |
PMID:23038007 |
|
NCBI chr20:32,629,537...32,639,559
|
|
G |
Rbp7 |
retinol binding protein 7 |
increases expression |
EXP |
2-anthramine results in increased expression of RBP7 mRNA |
CTD |
PMID:23038007 |
|
NCBI chr 5:159,889,723...159,894,338
Ensembl chr 5:159,889,723...159,894,339
|
|
G |
Sgcb |
sarcoglycan, beta |
increases expression |
EXP |
2-anthramine results in increased expression of SGCB mRNA |
CTD |
PMID:23038007 |
|
NCBI chr14:34,563,614...34,578,614
Ensembl chr14:34,563,608...34,578,583
|
|
G |
Slc25a37 |
solute carrier family 25 member 37 |
increases expression |
EXP |
2-anthramine results in increased expression of SLC25A37 mRNA |
CTD |
PMID:23038007 |
|
NCBI chr15:44,534,280...44,576,697
Ensembl chr15:44,536,727...44,577,199
|
|
G |
Sox4 |
SRY-box transcription factor 4 |
increases expression |
EXP |
2-anthramine results in increased expression of SOX4 mRNA |
CTD |
PMID:23038007 |
|
NCBI chr17:35,667,809...35,672,515
Ensembl chr17:35,667,537...35,673,665
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
increases expression |
EXP |
2-anthramine results in increased expression of SPP1 mRNA |
CTD |
PMID:31714650 |
|
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
|
|
G |
Thyn1 |
thymocyte nuclear protein 1 |
increases expression |
EXP |
2-anthramine results in increased expression of THYN1 mRNA |
CTD |
PMID:23038007 |
|
NCBI chr 8:25,406,563...25,415,445
Ensembl chr 8:25,406,500...25,415,445
|
|
G |
Tnfrsf9 |
TNF receptor superfamily member 9 |
increases expression |
EXP |
2-anthramine results in increased expression of TNFRSF9 mRNA |
CTD |
PMID:23038007 |
|
NCBI chr 5:161,381,662...161,408,003
Ensembl chr 5:161,381,662...161,408,000
|
|
G |
Vxn |
vexin |
increases expression |
EXP |
2-anthramine results in increased expression of VXN mRNA |
CTD |
PMID:23038007 |
|
NCBI chr 5:9,659,213...9,684,684
Ensembl chr 5:9,659,213...9,684,684
|
|
|
G |
Acp2 |
acid phosphatase 2, lysosomal |
multiple interactions affects expression |
ISO |
[naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] affects the expression of ACP2 protein anthracene affects the expression of ACP2 protein |
CTD |
PMID:28803881 |
|
NCBI chr 3:77,175,022...77,185,180
Ensembl chr 3:77,175,895...77,185,680
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions affects binding increases activity affects localization |
ISO EXP |
2-oxohexyl isothiocyanate inhibits the reaction [anthracene affects the localization of AHR protein]; [acenaphthene co-treated with anthracene co-treated with 1,12-benzoperylene co-treated with 1,2,5,6-dibenzanthracene co-treated with fluorene co-treated with naphthalene co-treated with phenanthrene] results in increased activity of AHR protein; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AHR protein; AHR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AR protein]; AHR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of ESR1 protein]; AHRR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AHR protein]; alyssin inhibits the reaction [anthracene affects the localization of AHR protein]; sulforaphane affects the reaction [anthracene affects the localization of AHR protein] anthracene binds to AHR protein anthracene results in increased activity of AHR protein |
CTD |
PMID:3024361 PMID:17665671 PMID:19362136 PMID:28710019 PMID:30980910 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Ahrr |
aryl-hydrocarbon receptor repressor |
multiple interactions |
ISO |
[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AHRR protein; AHRR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AHR protein]; AHRR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of CYP1A1 protein] |
CTD |
PMID:28710019 PMID:30980910 |
|
NCBI chr 1:28,993,634...29,088,673
Ensembl chr 1:28,993,634...29,088,673
|
|
G |
Ar |
androgen receptor |
multiple interactions |
ISO |
[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AR protein; AHR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of AR protein]; anthracene inhibits the reaction [Androgens results in increased activity of AR protein]; anthracene inhibits the reaction [Metribolone results in increased activity of AR protein] |
CTD |
PMID:18324785 PMID:28377212 PMID:30980910 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
multiple interactions |
ISO |
[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] affects the expression of ARNT protein; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of ARNT mRNA; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of ARNT mRNA |
CTD |
PMID:28710019 |
|
NCBI chr 2:182,997,731...183,056,584
Ensembl chr 2:182,997,736...183,056,580
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions affects expression |
ISO |
[naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] affects the expression of BAX protein anthracene affects the expression of BAX protein |
CTD |
PMID:28803881 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Casp3 |
caspase 3 |
increases expression multiple interactions |
ISO |
anthracene results in increased expression of CASP3 protein [naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] results in increased expression of CASP3 protein |
CTD |
PMID:28803881 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Ccna2 |
cyclin A2 |
decreases expression multiple interactions |
ISO |
anthracene results in decreased expression of CCNA2 protein [naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] results in decreased expression of CCNA2 protein |
CTD |
PMID:28803881 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnd1 |
cyclin D1 |
increases expression multiple interactions |
ISO |
anthracene results in increased expression of CCND1 protein [naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] results in increased expression of CCND1 protein |
CTD |
PMID:28803881 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
increases expression multiple interactions |
ISO |
anthracene results in increased expression of CDK2 protein [naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] results in increased expression of CDK2 protein |
CTD |
PMID:28803881 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Comt |
catechol-O-methyltransferase |
multiple interactions |
ISO |
[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] affects the expression of COMT mRNA; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of and affects the activity of COMT protein |
CTD |
PMID:28710019 |
|
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
increases expression multiple interactions |
ISO |
anthracene results in increased expression of CYP19A1 protein [naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] affects the expression of CYP19A1 protein |
CTD |
PMID:28803881 |
|
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions increases expression increases activity |
EXP ISO |
anthracene inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA] anthracene results in increased expression of CYP1A1 mRNA [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] affects the expression of CYP1A1 mRNA; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] affects the expression of CYP1A1 protein; [naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of CYP1A1 protein; AHRR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in decreased expression of CYP1A1 protein]; alyssin inhibits the reaction [anthracene results in increased activity of CYP1A1 protein]; sulforaphane inhibits the reaction [anthracene results in increased activity of CYP1A1 protein] |
CTD |
PMID:15315710 PMID:19362136 PMID:21668866 PMID:28710019 PMID:30980910 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases activity affects binding multiple interactions |
ISO |
anthracene results in increased activity of CYP1A2 protein anthracene binds to CYP1A2 protein [acenaphthylene co-treated with acenaphthene co-treated with dibenzofuran co-treated with fluorene co-treated with phenanthrene co-treated with anthracene] results in increased expression of CYP1A2 mRNA alyssin inhibits the reaction [anthracene results in increased activity of CYP1A2 protein]; sulforaphane inhibits the reaction [anthracene results in increased activity of CYP1A2 protein] |
CTD |
PMID:7750161 PMID:8001243 PMID:19362136 PMID:32278787 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
increases expression |
ISO |
anthracene results in increased expression of CYP1B1 mRNA |
CTD |
PMID:21668866 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions |
ISO |
[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of ESR1 protein; AHR protein affects the reaction [[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of ESR1 protein] |
CTD |
PMID:30980910 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Nfkb2 |
nuclear factor kappa B subunit 2 |
multiple interactions |
ISO |
[naphthalene co-treated with phenanthrene co-treated with anthracene co-treated with fluoranthene co-treated with pyrene] results in increased expression of NFKB2 protein |
CTD |
PMID:30980910 |
|
NCBI chr 1:245,164,586...245,173,225
Ensembl chr 1:245,165,950...245,173,213
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
increases activity |
ISO |
anthracene results in increased activity of NR1I3 protein |
CTD |
PMID:28927721 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
TNF protein promotes the reaction [anthracene results in increased expression of CXCL8 mRNA] |
CTD |
PMID:18434080 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
|
G |
Cat |
catalase |
multiple interactions |
ISO |
CAT protein inhibits the reaction [Anthralin results in increased expression of CXCL8 mRNA] |
CTD |
PMID:9628260 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccnb1 |
cyclin B1 |
increases expression |
ISO |
Anthralin results in increased expression of CCNB1 protein |
CTD |
PMID:20025956 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Chek1 |
checkpoint kinase 1 |
increases expression |
ISO |
Anthralin results in increased expression of CHEK1 protein |
CTD |
PMID:20025956 |
|
NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009
|
|
G |
Csf2 |
colony stimulating factor 2 |
increases expression |
ISO |
Anthralin results in increased expression of CSF2 mRNA |
CTD |
PMID:9628260 |
|
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
decreases activity |
ISO |
Anthralin results in decreased activity of CYP1A2 protein |
CTD |
PMID:33438235 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Fosl1 |
FOS like 1, AP-1 transcription factor subunit |
increases expression |
ISO |
Anthralin results in increased expression of FOSL1 protein |
CTD |
PMID:20025956 |
|
NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
multiple interactions |
ISO |
Anthralin inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate] |
CTD |
PMID:23769903 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Hells |
helicase, lymphoid specific |
increases expression |
ISO |
Anthralin results in increased expression of HELLS protein |
CTD |
PMID:20025956 |
|
NCBI chr 1:236,701,704...236,748,239
Ensembl chr 1:236,701,758...236,746,844
|
|
G |
Il1a |
interleukin 1 alpha |
increases expression multiple interactions |
ISO |
Anthralin results in increased expression of IL1A mRNA; Anthralin results in increased expression of IL1A protein Plant Extracts inhibits the reaction [Anthralin results in increased expression of IL1A mRNA]; Plant Extracts inhibits the reaction [Anthralin results in increased expression of IL1A protein] |
CTD |
PMID:7665919 PMID:8435107 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1rl1 |
interleukin 1 receptor-like 1 |
increases expression |
ISO |
Anthralin results in increased expression of IL1RL1 protein |
CTD |
PMID:20025956 |
|
NCBI chr 9:42,661,694...42,727,266
Ensembl chr 9:42,697,192...42,727,256
|
|
G |
Il6 |
interleukin 6 |
increases expression |
ISO |
Anthralin results in increased expression of IL6 mRNA |
CTD |
PMID:9628260 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Mcm3 |
minichromosome maintenance complex component 3 |
increases expression |
ISO |
Anthralin results in increased expression of MCM3 protein |
CTD |
PMID:20025956 |
|
NCBI chr 9:23,219,169...23,237,314
Ensembl chr 9:23,219,169...23,237,314
|
|
G |
Nup54 |
nucleoporin 54 |
increases expression |
ISO |
Anthralin results in increased expression of NUP54 protein |
CTD |
PMID:20025956 |
|
NCBI chr14:15,617,630...15,636,029
Ensembl chr14:15,617,679...15,636,028
|
|
G |
Phex |
phosphate regulating endopeptidase X-linked |
increases expression |
ISO |
Anthralin results in increased expression of PHEX protein |
CTD |
PMID:20025956 |
|
NCBI chr X:37,607,553...37,856,183
Ensembl chr X:37,610,760...37,854,469
|
|
G |
Pik3r5 |
phosphoinositide-3-kinase, regulatory subunit 5 |
increases expression |
ISO |
Anthralin results in increased expression of PIK3R5 protein |
CTD |
PMID:20025956 |
|
NCBI chr10:53,132,585...53,200,663
Ensembl chr10:53,132,603...53,199,374
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
increases expression |
ISO |
Anthralin results in increased expression of PTGS2 mRNA |
CTD |
PMID:8989914 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Rad51ap1 |
RAD51 associated protein 1 |
increases expression |
ISO |
Anthralin results in increased expression of RAD51AP1 protein |
CTD |
PMID:20025956 |
|
NCBI chr 4:159,759,454...159,772,473
Ensembl chr 4:159,759,459...159,772,524
|
|
G |
Rif1 |
replication timing regulatory factor 1 |
increases expression |
ISO |
Anthralin results in increased expression of RIF1 protein |
CTD |
PMID:20025956 |
|
NCBI chr 3:36,554,689...36,607,961
Ensembl chr 3:36,554,697...36,603,617
|
|
G |
Slc2a1 |
solute carrier family 2 member 1 |
increases expression |
ISO |
Anthralin results in increased expression of SLC2A1 protein |
CTD |
PMID:20025956 |
|
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
|
|
G |
Stmn1 |
stathmin 1 |
increases expression |
ISO |
Anthralin results in increased expression of STMN1 protein |
CTD |
PMID:20025956 |
|
NCBI chr 5:146,680,757...146,687,154
Ensembl chr 5:146,681,436...146,687,154
|
|
G |
Tfrc |
transferrin receptor |
increases expression |
ISO |
Anthralin results in increased expression of TFRC protein |
CTD |
PMID:20025956 |
|
NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
increases expression |
ISO |
Anthralin results in increased expression of TGFB1 mRNA |
CTD |
PMID:8148055 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tnf |
tumor necrosis factor |
increases expression |
ISO |
Anthralin results in increased expression of TNF mRNA; Anthralin results in increased expression of TNF protein |
CTD |
PMID:9628260 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Ugt1a2 |
UDP glucuronosyltransferase 1 family, polypeptide A2 |
increases glucuronidation |
ISO |
UGT1A3 protein results in increased glucuronidation of Anthralin |
CTD |
PMID:15117964 |
|
NCBI chr 9:88,791,216...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Vegfa |
vascular endothelial growth factor A |
increases expression |
ISO |
Anthralin results in increased expression of VEGFA protein |
CTD |
PMID:20025956 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions |
ISO |
2,6-dihydroxyanthraquinone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein] |
CTD |
PMID:19269596 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Alb |
albumin |
affects binding |
ISO |
2,6-dihydroxyanthraquinone binds to ALB protein |
CTD |
PMID:16404478 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression |
ISO |
2,6-dihydroxyanthraquinone results in increased expression of CYP1A1 mRNA |
CTD |
PMID:11502733 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
increases expression |
ISO |
2,6-dihydroxyanthraquinone results in increased expression of CYP1B1 mRNA |
CTD |
PMID:11502733 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase family 1 member A1 |
increases glucuronidation |
ISO |
UGT1A1 protein results in increased glucuronidation of 2,6-dihydroxyanthraquinone |
CTD |
PMID:12756209 PMID:14557274 |
|
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a9 |
UDP glucuronosyltransferase family 1 member A9 |
increases glucuronidation |
ISO |
UGT1A9 protein results in increased glucuronidation of 2,6-dihydroxyanthraquinone |
CTD |
PMID:14557274 |
|
NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase family 1 member A1 |
increases glucuronidation |
ISO |
UGT1A1 protein results in increased glucuronidation of anthrarobin |
CTD |
PMID:14557274 |
|
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a9 |
UDP glucuronosyltransferase family 1 member A9 |
increases glucuronidation |
ISO |
UGT1A9 protein results in increased glucuronidation of anthrarobin |
CTD |
PMID:14557274 |
|
NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
multiple interactions |
ISO |
aurantio-obtusin inhibits the reaction [ABCB11 protein results in increased transport of Taurodeoxycholic Acid] |
CTD |
PMID:35101544 |
|
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
|
|
G |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
increases expression |
ISO |
aurantio-obtusin results in increased expression of ACSL4 protein |
CTD |
PMID:35995123 |
|
NCBI chr X:105,942,794...106,006,573
Ensembl chr X:105,942,799...106,006,427
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression |
ISO |
aurantio-obtusin results in increased expression of BAX protein |
CTD |
PMID:35995123 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression |
ISO |
aurantio-obtusin results in decreased expression of BCL2 protein |
CTD |
PMID:35995123 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Casp1 |
caspase 1 |
increases expression |
ISO |
aurantio-obtusin results in increased expression of CASP1 mRNA |
CTD |
PMID:34718095 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp3 |
caspase 3 |
increases cleavage multiple interactions |
ISO |
aurantio-obtusin results in increased cleavage of CASP3 protein aurantio-obtusin results in increased expression of and results in increased cleavage of CASP3 protein |
CTD |
PMID:34718095 PMID:35995123 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
increases expression |
ISO |
aurantio-obtusin results in increased expression of CCL2 mRNA |
CTD |
PMID:34718095 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Crebbp |
CREB binding protein |
increases phosphorylation |
ISO |
aurantio-obtusin results in increased phosphorylation of CREBBP protein |
CTD |
PMID:35995123 |
|
NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
increases expression |
ISO |
aurantio-obtusin results in increased expression of GPT protein |
CTD |
PMID:34718095 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Hamp |
hepcidin antimicrobial peptide |
decreases expression |
ISO |
aurantio-obtusin results in decreased expression of HAMP mRNA |
CTD |
PMID:34718095 |
|
NCBI chr 1:86,170,926...86,172,865
Ensembl chr 1:86,170,901...86,172,891
|
|
G |
Il18 |
interleukin 18 |
increases expression |
ISO |
aurantio-obtusin results in increased expression of IL18 mRNA; aurantio-obtusin results in increased expression of IL18 protein |
CTD |
PMID:34718095 |
|
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il1b |
interleukin 1 beta |
increases expression |
ISO |
aurantio-obtusin results in increased expression of IL1B mRNA; aurantio-obtusin results in increased expression of IL1B protein |
CTD |
PMID:34718095 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
increases expression multiple interactions |
ISO |
aurantio-obtusin results in increased expression of IL6 mRNA aurantio-obtusin inhibits the reaction [Bleomycin results in increased secretion of IL6 protein] |
CTD |
PMID:28299617 PMID:34718095 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Kcnn4 |
potassium calcium-activated channel subfamily N member 4 |
increases expression |
ISO |
aurantio-obtusin results in increased expression of KCNN4 mRNA; aurantio-obtusin results in increased expression of KCNN4 protein |
CTD |
PMID:34718095 |
|
NCBI chr 1:79,956,380...79,974,354
Ensembl chr 1:79,959,322...79,974,340
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
decreases expression |
ISO |
aurantio-obtusin results in decreased expression of NFKB1 mRNA |
CTD |
PMID:34718095 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
increases expression |
ISO |
aurantio-obtusin results in increased expression of NLRP3 mRNA; aurantio-obtusin results in increased expression of NLRP3 protein |
CTD |
PMID:34718095 |
|
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
decreases expression |
ISO |
aurantio-obtusin results in decreased expression of RELA protein |
CTD |
PMID:34718095 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Slc22a6 |
solute carrier family 22 member 6 |
decreases activity |
ISO |
aurantio-obtusin results in decreased activity of SLC22A6 protein |
CTD |
PMID:29045746 |
|
NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173
|
|
G |
Slc22a8 |
solute carrier family 22 member 8 |
decreases activity |
ISO |
aurantio-obtusin results in decreased activity of SLC22A8 protein |
CTD |
PMID:29045746 |
|
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
|
|
G |
Spn |
sialophorin |
increases expression |
ISO |
aurantio-obtusin results in increased expression of SPN mRNA |
CTD |
PMID:34718095 |
|
NCBI chr 1:181,746,937...181,759,564
Ensembl chr 1:181,746,429...181,759,628
|
|
G |
Tnf |
tumor necrosis factor |
increases expression |
ISO |
aurantio-obtusin results in increased expression of TNF mRNA |
CTD |
PMID:34718095 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Xpo1 |
exportin 1 |
decreases expression |
ISO |
aurantio-obtusin results in decreased expression of XPO1 mRNA |
CTD |
PMID:34718095 |
|
NCBI chr14:97,233,282...97,275,536
Ensembl chr14:97,233,270...97,275,498
|
|
|
G |
Ahr |
aryl hydrocarbon receptor |
increases activity |
EXP |
capoamycin results in increased activity of AHR protein |
CTD |
PMID:25500124 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions |
ISO |
danthron inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein] |
CTD |
PMID:19269596 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
multiple interactions increases expression |
ISO |
danthron affects the localization of and results in increased expression of AIFM1 protein danthron results in increased expression of AIFM1 mRNA |
CTD |
PMID:21126053 |
|
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
|
|
G |
Alb |
albumin |
affects binding |
ISO |
danthron binds to ALB protein |
CTD |
PMID:16404478 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Atf6 |
activating transcription factor 6 |
increases expression |
ISO |
danthron results in increased expression of ATF6 protein |
CTD |
PMID:21126053 |
|
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression |
ISO |
danthron results in increased expression of BAX protein |
CTD |
PMID:21126053 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression |
ISO |
danthron results in decreased expression of BCL2 protein |
CTD |
PMID:21126053 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
increases expression decreases expression |
ISO |
danthron results in increased expression of BCL2L1 protein danthron results in decreased expression of BCL2L1 protein |
CTD |
PMID:21126053 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
|
|
G |
Bid |
BH3 interacting domain death agonist |
increases expression |
ISO |
danthron results in increased expression of BID protein |
CTD |
PMID:21126053 |
|
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
|
|
G |
Birc2 |
baculoviral IAP repeat-containing 2 |
decreases expression |
ISO |
danthron results in decreased expression of BIRC2 protein |
CTD |
PMID:21126053 |
|
NCBI chr 8:4,968,856...4,989,325
Ensembl chr 8:4,968,842...4,988,732
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
increases expression |
ISO |
danthron results in increased expression of BIRC3 protein |
CTD |
PMID:21126053 |
|
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
decreases expression |
ISO |
danthron results in decreased expression of BIRC5 protein |
CTD |
PMID:21126053 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases expression |
ISO |
benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [danthron results in increased activity of CASP3 protein]; danthron results in increased activity of and results in increased expression of CASP3 protein danthron results in increased expression of CASP3 mRNA |
CTD |
PMID:21126053 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
multiple interactions increases expression |
ISO |
benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [danthron results in increased activity of CASP8 protein]; danthron results in increased activity of and results in increased expression of CASP8 protein danthron results in increased expression of CASP8 mRNA |
CTD |
PMID:21126053 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions increases expression |
ISO |
benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [danthron results in increased activity of CASP9 protein]; danthron results in increased activity of and results in increased expression of CASP9 protein danthron results in increased expression of CASP9 mRNA |
CTD |
PMID:21126053 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cycs |
cytochrome c, somatic |
multiple interactions |
ISO |
danthron affects the localization of and results in increased expression of CYCS protein |
CTD |
PMID:21126053 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
decreases activity |
ISO |
danthron results in decreased activity of CYP1A2 protein |
CTD |
PMID:33438235 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression |
ISO |
danthron results in increased expression of DDIT3 protein |
CTD |
PMID:21126053 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Diablo |
diablo, IAP-binding mitochondrial protein |
increases expression |
ISO |
danthron results in increased expression of DIABLO protein |
CTD |
PMID:21126053 |
|
NCBI chr12:33,055,784...33,070,401
Ensembl chr12:33,055,263...33,070,387
|
|
G |
Endog |
endonuclease G |
increases expression multiple interactions |
ISO |
danthron results in increased expression of ENDOG mRNA danthron affects the localization of and results in increased expression of ENDOG protein |
CTD |
PMID:21126053 |
|
NCBI chr 3:13,449,113...13,451,715
Ensembl chr 3:13,449,086...13,451,932
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression |
ISO |
danthron results in increased expression of FAS protein |
CTD |
PMID:21126053 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Faslg |
Fas ligand |
increases expression |
ISO |
danthron results in increased expression of FASLG protein |
CTD |
PMID:21126053 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
increases expression |
ISO |
danthron results in increased expression of HSPA5 protein |
CTD |
PMID:21126053 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Sod1 |
superoxide dismutase 1 |
decreases expression |
ISO |
danthron results in decreased expression of SOD1 protein |
CTD |
PMID:21126053 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
decreases expression |
ISO |
danthron results in decreased expression of SOD2 protein |
CTD |
PMID:21126053 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Tnfsf10 |
TNF superfamily member 10 |
increases expression |
ISO |
danthron results in increased expression of TNFSF10 protein |
CTD |
PMID:21126053 |
|
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
|
|
G |
Xiap |
X-linked inhibitor of apoptosis |
decreases expression |
ISO |
danthron results in decreased expression of XIAP protein |
CTD |
PMID:21126053 |
|
NCBI chr X:120,890,537...120,938,413
Ensembl chr X:120,897,907...120,934,700
|
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
decreases expression |
EXP |
chrysophanic acid results in decreased expression of ABCB11 mRNA; chrysophanic acid results in decreased expression of ABCB11 protein |
CTD |
PMID:28161596 |
|
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
increases expression |
EXP |
chrysophanic acid results in increased expression of ABCC2 mRNA; chrysophanic acid results in increased expression of ABCC2 protein |
CTD |
PMID:28161596 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abcc4 |
ATP binding cassette subfamily C member 4 |
increases expression |
EXP |
chrysophanic acid results in increased expression of ABCC4 mRNA; chrysophanic acid results in increased expression of ABCC4 protein |
CTD |
PMID:28161596 |
|
NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions |
ISO |
chrysophanic acid inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein] |
CTD |
PMID:19269596 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
decreases phosphorylation |
ISO |
chrysophanic acid results in decreased phosphorylation of AKT1 protein |
CTD |
PMID:30300626 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Bak1 |
BCL2-antagonist/killer 1 |
increases expression |
ISO |
chrysophanic acid results in increased expression of BAK1 protein |
CTD |
PMID:30300626 |
|
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression |
ISO |
chrysophanic acid results in increased expression of BAX protein |
CTD |
PMID:30300626 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
decreases activity |
ISO |
chrysophanic acid results in decreased activity of CYP1A1 protein |
CTD |
PMID:27633141 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
decreases activity multiple interactions increases metabolic processing |
ISO |
chrysophanic acid results in decreased activity of CYP1A2 protein [CYP1A2 protein results in increased metabolism of chrysophanic acid] which results in increased chemical synthesis of 2-hydroxychrysophanol |
CTD |
PMID:27633141 PMID:29698620 PMID:33438235 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
decreases activity |
ISO |
chrysophanic acid results in decreased activity of CYP1B1 protein |
CTD |
PMID:27633141 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
multiple interactions increases metabolic processing |
ISO |
[CYP2B6 protein results in increased metabolism of chrysophanic acid] which results in increased chemical synthesis of aloe emodin |
CTD |
PMID:29698620 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
increases metabolic processing increases chemical synthesis multiple interactions |
ISO |
CYP3A4 protein results in increased metabolism of chrysophanic acid CYP3A4 protein results in increased chemical synthesis of chrysophanic acid metabolite [CYP3A4 protein results in increased metabolism of chrysophanic acid] which results in increased chemical synthesis of 2-hydroxychrysophanol; [CYP3A4 protein results in increased metabolism of chrysophanic acid] which results in increased chemical synthesis of aloe emodin |
CTD |
PMID:29698620 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp7a1 |
cytochrome P450 family 7 subfamily A member 1 |
increases expression |
EXP |
chrysophanic acid results in increased expression of CYP7A1 mRNA; chrysophanic acid results in increased expression of CYP7A1 protein |
CTD |
PMID:28161596 |
|
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
|
|
G |
Cyp8b1 |
cytochrome P450 family 8 subfamily B member 1 |
decreases expression |
EXP |
chrysophanic acid results in decreased expression of CYP8B1 mRNA; chrysophanic acid results in decreased expression of CYP8B1 protein |
CTD |
PMID:28161596 |
|
NCBI chr 8:121,578,123...121,580,093
Ensembl chr 8:121,557,062...121,580,166
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression |
ISO |
chrysophanic acid results in increased expression of DDIT3 protein |
CTD |
PMID:30300626 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
increases phosphorylation multiple interactions |
ISO |
chrysophanic acid results in increased phosphorylation of EIF2AK3 protein Acetylcysteine inhibits the reaction [chrysophanic acid results in increased phosphorylation of EIF2AK3 protein] |
CTD |
PMID:30300626 |
|
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
|
|
G |
Eif2s1 |
eukaryotic translation initiation factor 2 subunit alpha |
increases phosphorylation multiple interactions |
ISO |
chrysophanic acid results in increased phosphorylation of EIF2S1 protein Acetylcysteine inhibits the reaction [chrysophanic acid results in increased phosphorylation of EIF2S1 protein] |
CTD |
PMID:30300626 |
|
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
increases expression |
ISO |
chrysophanic acid results in increased expression of ERN1 protein |
CTD |
PMID:30300626 |
|
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
decreases phosphorylation |
ISO |
chrysophanic acid results in decreased phosphorylation of MAPK1 protein |
CTD |
PMID:30300626 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
affects phosphorylation |
ISO |
chrysophanic acid affects the phosphorylation of MAPK14 protein |
CTD |
PMID:30300626 |
|
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
decreases phosphorylation |
ISO |
chrysophanic acid results in decreased phosphorylation of MAPK3 protein |
CTD |
PMID:30300626 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
affects phosphorylation |
ISO |
chrysophanic acid affects the phosphorylation of MAPK8 protein |
CTD |
PMID:30300626 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Pcna |
proliferating cell nuclear antigen |
decreases expression |
ISO |
chrysophanic acid results in decreased expression of PCNA protein |
CTD |
PMID:30300626 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Rps6 |
ribosomal protein S6 |
decreases phosphorylation |
ISO |
chrysophanic acid results in decreased phosphorylation of RPS6 protein |
CTD |
PMID:30300626 |
|
NCBI chr 5:101,371,716...101,374,576
Ensembl chr 5:101,371,136...101,374,602 Ensembl chr 5:101,371,136...101,374,602
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase B1 |
decreases phosphorylation |
ISO |
chrysophanic acid results in decreased phosphorylation of RPS6KB1 protein |
CTD |
PMID:30300626 |
|
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
|
|
G |
Slc10a1 |
solute carrier family 10 member 1 |
decreases expression |
EXP |
chrysophanic acid results in decreased expression of SLC10A1 mRNA; chrysophanic acid results in decreased expression of SLC10A1 protein |
CTD |
PMID:28161596 |
|
NCBI chr 6:100,613,045...100,626,670
Ensembl chr 6:100,613,045...100,626,670
|
|
G |
Slc22a6 |
solute carrier family 22 member 6 |
decreases activity |
ISO |
chrysophanic acid results in decreased activity of SLC22A6 protein |
CTD |
PMID:29045746 |
|
NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173
|
|
G |
Slc22a8 |
solute carrier family 22 member 8 |
decreases activity |
ISO |
chrysophanic acid results in decreased activity of SLC22A8 protein |
CTD |
PMID:29045746 |
|
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
|
|
G |
Sult1a1 |
sulfotransferase family 1A member 1 |
decreases activity |
ISO |
chrysophanic acid results in decreased activity of SULT1A1 protein |
CTD |
PMID:27633141 |
|
NCBI chr 1:181,272,022...181,276,750
Ensembl chr 1:181,272,023...181,275,562
|
|
G |
Ugt1a9 |
UDP glucuronosyltransferase family 1 member A9 |
increases glucuronidation |
ISO |
UGT1A9 protein results in increased glucuronidation of chrysophanic acid |
CTD |
PMID:24854283 |
|
NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
|
G |
Cyp2c6 |
cytochrome P450, family 2, subfamily C, polypeptide 6 |
increases chemical synthesis |
ISO |
CYP2C19 protein results in increased chemical synthesis of 1,3,8-trihydroxy-6-hydroxymethylanthraquinone |
CTD |
PMID:27989148 |
|
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
increases chemical synthesis |
ISO |
CYP3A4 protein results in increased chemical synthesis of 1,3,8-trihydroxy-6-hydroxymethylanthraquinone |
CTD |
PMID:27989148 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
|
G |
H2ax |
H2A.X variant histone |
increases phosphorylation |
EXP |
Disperse Blue 1 results in increased phosphorylation of H2AX protein |
CTD |
PMID:33211169 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
|
|
G |
Krt14 |
keratin 14 |
increases expression |
EXP |
Disperse Blue 1 results in increased expression of KRT14 protein |
CTD |
PMID:33211169 |
|
NCBI chr10:85,137,786...85,142,054
Ensembl chr10:85,066,802...85,171,799
|
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
increases expression multiple interactions affects activity decreases expression |
EXP ISO |
Emodin results in increased expression of ABCB11 mRNA; Emodin results in increased expression of ABCB11 protein 2,3,5,4'-tetrahydroxystilbene-2-O-beta-D-glucopyranoside affects the reaction [[Emodin affects the activity of ABCB11 protein] which affects the export of Taurocholic Acid]; [2,3,5,4'-tetrahydroxystilbene-2-O-beta-D-glucopyranoside co-treated with Emodin] results in increased expression of ABCB11 protein; [Emodin affects the activity of ABCB11 protein] which affects the export of Taurocholic Acid dorsomorphin inhibits the reaction [Emodin results in decreased expression of ABCB11 mRNA]; Emodin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ABCB11 mRNA] Emodin results in decreased expression of ABCB11 mRNA; Emodin results in decreased expression of ABCB11 protein |
CTD |
PMID:28161596 PMID:30517764 PMID:35753641 |
|
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
multiple interactions increases expression |
ISO EXP |
Emodin inhibits the reaction [ABCB1 protein results in increased transport of Digoxin] Emodin results in increased expression of ABCB1A mRNA ABCB1A protein promotes the reaction [Emodin results in increased export of calcein AM] |
CTD |
PMID:19549930 PMID:24380838 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcb1b |
ATP-binding cassette, sub-family B member 1B |
increases expression |
EXP |
Emodin results in increased expression of ABCB1B mRNA |
CTD |
PMID:19549930 |
|
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
|
|
G |
Abcb4 |
ATP binding cassette subfamily B member 4 |
decreases expression |
EXP |
Emodin results in decreased expression of ABCB4 mRNA |
CTD |
PMID:28161596 |
|
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
increases expression multiple interactions decreases expression |
EXP ISO |
Emodin results in increased expression of ABCC2 mRNA [2,3,5,4'-tetrahydroxystilbene-2-O-beta-D-glucopyranoside co-treated with Emodin] results in decreased expression of ABCC2 protein; [2,3,5,4'-tetrahydroxystilbene-2-O-beta-D-glucopyranoside co-treated with Emodin] results in increased expression of ABCC2 protein Emodin results in decreased expression of ABCC2 mRNA Emodin results in decreased expression of ABCC2 mRNA; Emodin results in decreased expression of ABCC2 protein |
CTD |
PMID:19549930 PMID:28161596 PMID:30517764 PMID:35753641 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abcc3 |
ATP binding cassette subfamily C member 3 |
increases expression multiple interactions decreases expression |
EXP ISO |
Emodin results in increased expression of ABCC3 mRNA [2,3,5,4'-tetrahydroxystilbene-2-O-beta-D-glucopyranoside co-treated with Emodin] results in decreased expression of ABCC3 protein; [2,3,5,4'-tetrahydroxystilbene-2-O-beta-D-glucopyranoside co-treated with Emodin] results in increased expression of ABCC3 protein Emodin results in decreased expression of ABCC3 mRNA Emodin results in decreased expression of ABCC3 mRNA; Emodin results in decreased expression of ABCC3 protein |
CTD |
PMID:19549930 PMID:28161596 PMID:30517764 PMID:35753641 |
|
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
|
|
G |
Abcc4 |
ATP binding cassette subfamily C member 4 |
decreases expression multiple interactions |
EXP ISO |
Emodin results in decreased expression of ABCC4 mRNA; Emodin results in decreased expression of ABCC4 protein [2,3,5,4'-tetrahydroxystilbene-2-O-beta-D-glucopyranoside co-treated with Emodin] results in increased expression of ABCC4 protein Emodin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of ABCC4 mRNA] |
CTD |
PMID:28161596 PMID:30517764 PMID:35753641 |
|
NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283
|
|
G |
Abcc6 |
ATP binding cassette subfamily C member 6 |
increases expression |
EXP |
Emodin results in increased expression of ABCC6 mRNA |
CTD |
PMID:19549930 |
|
NCBI chr 1:96,447,224...96,501,464
Ensembl chr 1:96,447,251...96,501,464
|
|
G |
Acta1 |
actin, alpha 1, skeletal muscle |
decreases expression |
ISO |
Emodin results in decreased expression of ACTA1 mRNA |
CTD |
PMID:16045814 |
|
NCBI chr19:51,883,709...51,886,735
Ensembl chr19:51,883,715...51,886,742
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
decreases expression multiple interactions |
EXP |
Emodin results in decreased expression of ACTA2 protein 2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine promotes the reaction [Emodin inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]]; Emodin inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]; Emodin inhibits the reaction [Thioacetamide results in increased expression of ACTA2 protein]; NOTCH1 protein inhibits the reaction [Emodin inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]] |
CTD |
PMID:15288473 PMID:27989784 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Adgre1 |
adhesion G protein-coupled receptor E1 |
multiple interactions |
ISO |
Emodin inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of ADGRE1 protein] |
CTD |
PMID:37023836 |
|
NCBI chr 9:2,242,476...2,398,000
Ensembl chr 9:2,242,474...2,398,000
|
|
G |
Agt |
angiotensinogen |
multiple interactions |
EXP |
Emodin inhibits the reaction [AGT protein results in increased expression of MYC protein]; Emodin inhibits the reaction [AGT protein results in increased expression of PCNA protein] |
CTD |
PMID:17886230 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions |
ISO |
Emodin binds to and results in increased activity of AHR protein Emodin binds to and results in increased activity of AHR protein; Emodin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein] |
CTD |
PMID:14644660 PMID:17869316 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Akr1b10 |
aldo-keto reductase family 1 member B10 |
decreases activity |
ISO |
Emodin results in decreased activity of AKR1B10 protein |
CTD |
PMID:35065925 |
|
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
|
|
G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
decreases activity |
ISO |
Emodin results in decreased activity of AKR1C3 protein |
CTD |
PMID:35065925 |
|
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
|
|
G |
Akr7a3 |
aldo-keto reductase family 7 member A3 |
decreases activity |
ISO |
Emodin results in decreased activity of AKR7A3 protein |
CTD |
PMID:35065925 |
|
NCBI chr 5:151,590,968...151,601,394
Ensembl chr 5:151,584,479...151,601,394
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions decreases phosphorylation decreases expression |
ISO EXP |
[arsenic trioxide co-treated with IFNA2 protein co-treated with Docosahexaenoic Acids co-treated with Emodin] results in decreased expression of AKT1 protein; Emodin inhibits the reaction [IL6 protein results in increased phosphorylation of AKT1 protein]; SB 203580 promotes the reaction [Emodin results in decreased phosphorylation of AKT1 protein]; U 0126 promotes the reaction [Emodin results in decreased phosphorylation of AKT1 protein] AKT activator SC79 inhibits the reaction [Emodin results in decreased phosphorylation of AKT1 protein]; Emodin inhibits the reaction [PDGFB protein results in increased phosphorylation of AKT1 protein] Emodin results in decreased expression of AKT1 mRNA |
CTD |
PMID:15288473 PMID:16045814 PMID:17077332 PMID:23848338 PMID:27032576 PMID:37393915 More...
|
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Akt2 |
AKT serine/threonine kinase 2 |
decreases phosphorylation multiple interactions |
ISO EXP |
Emodin results in decreased phosphorylation of AKT2 protein AKT activator SC79 inhibits the reaction [Emodin results in decreased phosphorylation of AKT2 protein] |
CTD |
PMID:37393915 |
|
NCBI chr 1:82,877,228...82,933,828
Ensembl chr 1:82,883,547...82,933,817
|
|
G |
Akt3 |
AKT serine/threonine kinase 3 |
decreases phosphorylation multiple interactions |
ISO EXP |
Emodin results in decreased phosphorylation of AKT3 protein AKT activator SC79 inhibits the reaction [Emodin results in decreased phosphorylation of AKT3 protein] |
CTD |
PMID:37393915 |
|
NCBI chr13:88,943,708...89,225,831
Ensembl chr13:88,946,091...89,225,708
|
|
G |
Ar |
androgen receptor |
multiple interactions |
ISO |
Emodin inhibits the reaction [cobaltous chloride results in increased expression of AR protein] |
CTD |
PMID:23212659 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Arg2 |
arginase 2 |
decreases expression |
ISO |
Emodin results in decreased expression of ARG2 mRNA |
CTD |
PMID:21319176 |
|
NCBI chr 6:97,936,002...97,961,379
Ensembl chr 6:97,936,002...97,961,378
|
|
G |
Arid3a |
AT-rich interaction domain 3A |
increases expression |
ISO |
Emodin results in increased expression of ARID3A mRNA |
CTD |
PMID:15612046 |
|
NCBI chr 7:9,755,291...9,781,260
Ensembl chr 7:9,755,294...9,780,599
|
|
G |
Atm |
ATM serine/threonine kinase |
increases expression increases phosphorylation |
ISO |
Emodin results in increased expression of ATM mRNA Emodin results in increased phosphorylation of ATM protein |
CTD |
PMID:16045814 PMID:20855424 |
|
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
|
|
G |
Bag5 |
BAG cochaperone 5 |
decreases expression |
ISO |
Emodin results in decreased expression of BAG5 mRNA |
CTD |
PMID:16045814 |
|
NCBI chr 6:130,768,467...130,772,122
Ensembl chr 6:130,768,141...130,772,970
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
affects expression increases expression multiple interactions decreases expression |
ISO EXP |
Emodin affects the expression of BAX protein Emodin results in increased expression of BAX protein 2,3,5,4'-tetrahydroxystilbene-2-O-beta-D-glucopyranoside promotes the reaction [Emodin results in increased expression of BAX protein] Emodin results in decreased expression of BAX protein 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [Emodin affects the expression of BAX protein]; SB 203580 affects the reaction [Emodin affects the expression of BAX protein]; U 0126 affects the reaction [Emodin affects the expression of BAX protein] |
CTD |
PMID:19549930 PMID:27032576 PMID:35753641 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression multiple interactions affects expression |
ISO EXP |
Emodin results in decreased expression of BCL2 mRNA; Emodin results in decreased expression of BCL2 protein [2,3,5,4'-tetrahydroxystilbene-2-O-beta-D-glucopyranoside co-treated with Emodin] results in decreased expression of BCL2 protein Emodin affects the expression of BCL2 protein 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [Emodin affects the expression of BCL2 protein]; SB 203580 affects the reaction [Emodin affects the expression of BCL2 protein]; U 0126 affects the reaction [Emodin affects the expression of BCL2 protein] |
CTD |
PMID:19549930 PMID:23848338 PMID:27032576 PMID:35753641 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bfar |
bifunctional apoptosis regulator |
decreases expression |
ISO |
Emodin results in decreased expression of BFAR mRNA |
CTD |
PMID:16045814 |
|
NCBI chr10:1,552,019...1,585,040
Ensembl chr10:1,552,072...1,585,038
|
|
G |
Bid |
BH3 interacting domain death agonist |
increases degradation multiple interactions |
ISO |
Emodin results in increased degradation of BID protein 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Emodin results in increased degradation of BID protein]; SB 203580 promotes the reaction [Emodin results in increased degradation of BID protein] |
CTD |
PMID:27032576 |
|
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
decreases expression |
ISO |
Emodin results in decreased expression of BIRC5 mRNA; Emodin results in decreased expression of BIRC5 protein |
CTD |
PMID:23848338 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Canx |
calnexin |
decreases expression |
ISO |
Emodin results in decreased expression of CANX mRNA |
CTD |
PMID:16045814 |
|
NCBI chr10:34,623,865...34,656,866
Ensembl chr10:34,625,191...34,656,821
|
|
G |
Casp1 |
caspase 1 |
increases expression multiple interactions |
ISO |
Emodin results in increased expression of CASP1 mRNA Emodin inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased cleavage of CASP1 protein] |
CTD |
PMID:15612046 PMID:37023836 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp12 |
caspase 12 |
decreases expression |
ISO |
Emodin results in decreased expression of CASP12 mRNA |
CTD |
PMID:21319176 |
|
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
|
|
G |
Casp3 |
caspase 3 |
increases expression multiple interactions affects expression increases cleavage increases activity |
ISO EXP |
Emodin results in increased expression of CASP3 protein [2,3,5,4'-tetrahydroxystilbene-2-O-beta-D-glucopyranoside co-treated with Emodin] results in increased cleavage of CASP3 protein; Emodin inhibits the reaction [Hydrogen Peroxide results in decreased expression of and results in increased cleavage of CASP3 protein]; Emodin inhibits the reaction [Hydrogen Peroxide results in increased activity of CASP3 protein]; Emodin inhibits the reaction [Oxidopamine results in decreased expression of and results in increased cleavage of CASP3 protein]; Emodin inhibits the reaction [Oxidopamine results in increased activity of CASP3 protein] Emodin affects the expression of CASP3 protein modified form Emodin results in increased cleavage of CASP3 protein 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Emodin results in increased cleavage of CASP3 protein]; 2-chloro-5-nitrobenzanilide inhibits the reaction [Emodin results in increased activity of CASP3 protein]; Emodin results in increased cleavage of and results in increased activity of CASP3 protein; SB 203580 inhibits the reaction [Emodin results in increased cleavage of CASP3 protein]; U 0126 promotes the reaction [Emodin results in increased cleavage of CASP3 protein] |
CTD |
PMID:19549930 PMID:23848338 PMID:25448808 PMID:27032576 PMID:34492313 PMID:34971761 PMID:35753641 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
multiple interactions increases activity |
ISO |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Emodin results in increased activity of CASP8 protein]; SB 203580 promotes the reaction [Emodin results in increased activity of CASP8 protein]; U 0126 promotes the reaction [Emodin results in increased activity of CASP8 protein] |
CTD |
PMID:27032576 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
increases expression multiple interactions |
ISO EXP |
Emodin results in increased expression of CASP9 mRNA [2,3,5,4'-tetrahydroxystilbene-2-O-beta-D-glucopyranoside co-treated with Emodin] results in increased cleavage of CASP9 protein |
CTD |
PMID:21319176 PMID:35753641 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions affects expression |
ISO EXP |
Emodin inhibits the reaction [Tobacco Smoke Pollution results in decreased activity of CAT protein] Emodin promotes the reaction [Cisplatin results in decreased activity of CAT protein] Emodin affects the expression of CAT protein |
CTD |
PMID:19549930 PMID:22271272 PMID:26139382 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cbr1 |
carbonyl reductase 1 |
decreases activity |
ISO |
Emodin results in decreased activity of CBR1 protein |
CTD |
PMID:35065925 |
|
NCBI chr11:32,860,571...32,862,981
Ensembl chr11:32,908,950...32,911,393 Ensembl chr11:32,908,950...32,911,393 Ensembl chr11:32,908,950...32,911,393
|
|
G |
Ccl26 |
C-C motif chemokine ligand 26 |
multiple interactions |
ISO |
Emodin inhibits the reaction [CCL26 protein binds to and results in increased activity of CCR3 protein] |
CTD |
PMID:37788752 |
|
NCBI chr12:21,109,384...21,114,336
Ensembl chr12:21,109,421...21,114,335
|
|
G |
Ccnb2 |
cyclin B2 |
decreases expression |
ISO |
Emodin results in decreased expression of CCNB2 mRNA |
CTD |
PMID:16045814 |
|
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
|
|
G |
Ccr3 |
C-C motif chemokine receptor 3 |
multiple interactions |
ISO |
Emodin inhibits the reaction [CCL26 protein binds to and results in increased activity of CCR3 protein] |
CTD |
PMID:37788752 |
|
NCBI chr 8:123,586,100...123,634,178
Ensembl chr 8:123,616,236...123,634,990
|
|
G |
Cdh1 |
cadherin 1 |
increases expression multiple interactions |
EXP |
Emodin results in increased expression of CDH1 protein 2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine promotes the reaction [Emodin inhibits the reaction [TGFB1 protein results in decreased expression of CDH1 protein]]; Emodin inhibits the reaction [TGFB1 protein results in decreased expression of CDH1 protein]; NOTCH1 protein inhibits the reaction [Emodin inhibits the reaction [TGFB1 protein results in decreased expression of CDH1 protein]] |
CTD |
PMID:27989784 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdk13 |
cyclin-dependent kinase 13 |
decreases expression |
ISO |
Emodin results in decreased expression of CDK13 mRNA |
CTD |
PMID:16045814 |
|
NCBI chr17:47,251,145...47,344,675
Ensembl chr17:47,251,163...47,341,721
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
decreases expression |
ISO |
Emodin results in decreased expression of CDK4 mRNA |
CTD |
PMID:16045814 |
|
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
|
|
G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
increases expression |
ISO |
Emodin results in increased expression of CDKN1C mRNA |
CTD |
PMID:21319176 |
|
NCBI chr 1:198,655,394...198,658,097
Ensembl chr 1:198,655,407...198,658,048
|
|
G |
Celsr3 |
cadherin, EGF LAG seven-pass G-type receptor 3 |
decreases expression |
ISO |
Emodin results in decreased expression of CELSR3 mRNA |
CTD |
PMID:16045814 |
|
NCBI chr 8:109,530,597...109,558,360
Ensembl chr 8:109,530,641...109,558,354
|
|
G |
Chia |
chitinase, acidic |
multiple interactions |
ISO |
Emodin inhibits the reaction [Ovalbumin results in increased expression of CHIA mRNA] |
CTD |
PMID:22484343 |
|
NCBI chr 2:193,614,374...193,656,532
Ensembl chr 2:193,614,114...193,656,533
|
|
G |
Cidec |
cell death-inducing DFFA-like effector c |
decreases expression |
ISO |
Emodin results in decreased expression of CIDEC mRNA |
CTD |
PMID:21319176 |
|
NCBI chr 4:146,569,288...146,582,173
Ensembl chr 4:146,569,289...146,582,173
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
decreases expression |
EXP |
Emodin results in decreased expression of COL1A1 mRNA |
CTD |
PMID:15288473 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Col1a2 |
collagen type I alpha 2 chain |
multiple interactions |
EXP |
Emodin inhibits the reaction [TGFB1 protein results in increased expression of COL1A2 mRNA] |
CTD |
PMID:19474275 |
|
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
decreases expression |
EXP |
Emodin results in decreased expression of COL3A1 mRNA |
CTD |
PMID:15288473 |
|
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
|
|
G |
Cops5 |
COP9 signalosome subunit 5 |
multiple interactions |
ISO |
[arsenic trioxide co-treated with IFNA2 protein co-treated with Docosahexaenoic Acids co-treated with Emodin] results in decreased expression of COPS5 protein |
CTD |
PMID:17077332 |
|
NCBI chr 5:9,192,233...9,210,498
Ensembl chr 5:9,192,100...9,210,731
|
|
G |
Csnk2a1 |
casein kinase 2 alpha 1 |
increases expression |
ISO |
Emodin results in increased expression of CSNK2A1 mRNA |
CTD |
PMID:21319176 |
|
NCBI chr 3:140,709,984...140,756,757
Ensembl chr 3:140,709,991...140,756,696
|
|
G |
Csnk2b |
casein kinase 2 beta |
increases expression |
ISO |
Emodin results in increased expression of CSNK2B mRNA |
CTD |
PMID:21319176 |
|
NCBI chr20:3,700,363...3,705,331
Ensembl chr20:3,698,733...3,707,133
|
|
G |
Ctsd |
cathepsin D |
decreases expression |
ISO |
Emodin results in decreased expression of CTSD mRNA |
CTD |
PMID:16045814 |
|
NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
multiple interactions |
EXP |
Emodin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CXCL1 mRNA] |
CTD |
PMID:18590720 |
|
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
multiple interactions |
EXP |
Emodin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CXCL2 mRNA] |
CTD |
PMID:18590720 |
|
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
|
|
G |
Cyld |
CYLD lysine 63 deubiquitinase |
increases expression |
ISO |
Emodin results in increased expression of CYLD mRNA |
CTD |
PMID:21319176 |
|
NCBI chr19:18,310,632...18,373,696
Ensembl chr19:18,314,019...18,373,658
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions decreases activity increases expression |
ISO |
Emodin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] Emodin results in decreased activity of CYP1A1 protein Emodin results in increased expression of CYP1A1 mRNA; Emodin results in increased expression of CYP1A1 protein |
CTD |
PMID:11502733 PMID:14644660 PMID:17012224 PMID:27633141 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions increases hydroxylation increases oxidation decreases activity |
ISO |
[CYP1A2 protein co-treated with Acetylcysteine] results in increased metabolism of Emodin metabolite CYP1A2 protein results in increased hydroxylation of Emodin CYP1A2 protein results in increased oxidation of Emodin Emodin results in decreased activity of CYP1A2 protein |
CTD |
PMID:27633141 PMID:27989148 PMID:30672276 PMID:33438235 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
increases expression decreases activity |
ISO |
Emodin results in increased expression of CYP1B1 mRNA; Emodin results in increased expression of CYP1B1 protein Emodin results in decreased activity of CYP1B1 protein |
CTD |
PMID:11502733 PMID:14990334 PMID:27633141 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp27a1 |
cytochrome P450, family 27, subfamily a, polypeptide 1 |
decreases expression multiple interactions |
EXP ISO |
Emodin results in decreased expression of CYP27A1 mRNA [2,3,5,4'-tetrahydroxystilbene-2-O-beta-D-glucopyranoside co-treated with Emodin] results in increased expression of CYP27A1 protein |
CTD |
PMID:28161596 PMID:30517764 PMID:35753641 |
|
NCBI chr 9:76,264,655...76,294,551
Ensembl chr 9:76,264,860...76,294,551
|
|
G |
Cyp2c6 |
cytochrome P450, family 2, subfamily C, polypeptide 6 |
increases oxidation decreases activity multiple interactions |
ISO |
CYP2C19 protein results in increased oxidation of Emodin Emodin results in decreased activity of CYP2C19 protein [CYP2C19 protein co-treated with Acetylcysteine] results in increased metabolism of Emodin metabolite |
CTD |
PMID:27989148 PMID:33438235 |
|
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
decreases activity |
ISO |
Emodin results in decreased activity of CYP2D6 protein |
CTD |
PMID:33438235 |
|
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions decreases activity affects response to substance increases hydroxylation increases oxidation |
ISO |
[CYP3A4 protein co-treated with Acetylcysteine] results in increased metabolism of Emodin metabolite Emodin results in decreased activity of CYP3A4 protein CYP3A4 protein affects the susceptibility to Emodin CYP3A4 protein results in increased hydroxylation of Emodin CYP3A4 protein results in increased oxidation of Emodin |
CTD |
PMID:27989148 PMID:30672276 PMID:33438235 PMID:34875353 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
increases hydroxylation |
ISO |
CYP3A5 protein results in increased hydroxylation of Emodin |
CTD |
PMID:30672276 |
|
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
|
|
G |
Cyp7a1 |
cytochrome P450 family 7 subfamily A member 1 |
decreases expression multiple interactions |
EXP |
Emodin results in decreased expression of CYP7A1 mRNA; Emodin results in decreased expression of CYP7A1 protein [2,3,5,4'-tetrahydroxystilbene-2-O-beta-D-glucopyranoside co-treated with Emodin] results in increased expression of CYP7A1 protein |
CTD |
PMID:28161596 PMID:35753641 |
|
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
|
|
G |
Cyp7b1 |
cytochrome P450 family 7 subfamily B member 1 |
decreases expression |
ISO |
Emodin results in decreased expression of CYP7B1 mRNA |
CTD |
PMID:30517764 |
|
NCBI chr 2:100,502,791...100,669,713
Ensembl chr 2:100,502,791...100,669,698
|
|
G |
Cyp8b1 |
cytochrome P450 family 8 subfamily B member 1 |
decreases expression |
EXP |
Emodin results in decreased expression of CYP8B1 mRNA; Emodin results in decreased expression of CYP8B1 protein |
CTD |
PMID:28161596 |
|
NCBI chr 8:121,578,123...121,580,093
Ensembl chr 8:121,557,062...121,580,166
|
|
G |
Dct |
dopachrome tautomerase |
decreases expression |
ISO |
Emodin results in decreased expression of DCT mRNA; Emodin results in decreased expression of DCT protein |
CTD |
PMID:26972667 |
|
NCBI chr15:95,062,006...95,100,863
Ensembl chr15:95,062,003...95,100,836
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression |
EXP |
Emodin results in increased expression of DDIT3 protein |
CTD |
PMID:19549930 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Dhfr |
dihydrofolate reductase |
decreases expression |
ISO |
Emodin results in decreased expression of DHFR mRNA |
CTD |
PMID:16045814 |
|
NCBI chr 2:23,585,876...23,611,199
Ensembl chr 2:23,586,031...23,613,713
|
|
G |
Dnajb1 |
DnaJ heat shock protein family (Hsp40) member B1 |
increases expression |
ISO |
Emodin results in increased expression of DNAJB1 mRNA |
CTD |
PMID:16045814 |
|
NCBI chr19:24,522,731...24,526,419
Ensembl chr19:24,522,717...24,526,458
|
|
G |
Dync1h1 |
dynein cytoplasmic 1 heavy chain 1 |
increases expression |
ISO |
Emodin results in increased expression of DYNC1H1 mRNA |
CTD |
PMID:21319176 |
|
NCBI chr 6:129,615,208...129,680,888
Ensembl chr 6:129,609,397...129,680,883
|
|
G |
E2f5 |
E2F transcription factor 5 |
increases expression |
ISO |
Emodin results in increased expression of E2F5 mRNA |
CTD |
PMID:16045814 |
|
NCBI chr 2:86,997,331...87,012,908
Ensembl chr 2:86,997,332...87,012,990
|
|
G |
Egr1 |
early growth response 1 |
multiple interactions |
EXP |
Emodin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of EGR1 mRNA] |
CTD |
PMID:18590720 |
|
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Ei24 |
EI24, autophagy associated transmembrane protein |
increases expression |
ISO |
Emodin results in increased expression of EI24 mRNA |
CTD |
PMID:16045814 |
|
NCBI chr 8:36,494,289...36,510,653
Ensembl chr 8:36,494,289...36,510,571
|
|
G |
Eif2b1 |
eukaryotic translation initiation factor 2B subunit alpha |
decreases expression |
ISO |
Emodin results in decreased expression of EIF2B1 mRNA |
CTD |
PMID:16045814 |
|
NCBI chr12:32,025,593...32,033,848
Ensembl chr12:32,025,557...32,046,601
|
|
G |
Esr1 |
estrogen receptor 1 |
increases activity |
ISO |
Emodin results in increased activity of ESR1 protein |
CTD |
PMID:19161236 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
increases activity |
ISO |
Emodin results in increased activity of ESR2 protein |
CTD |
PMID:19161236 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Fabp5 |
fatty acid binding protein 5 |
decreases expression |
ISO |
Emodin results in decreased expression of FABP5 mRNA |
CTD |
PMID:15612046 |
|
NCBI chr 2:91,765,056...91,768,716
Ensembl chr 2:91,765,056...91,853,773
|
|
G |
Fadd |
Fas associated via death domain |
increases expression |
ISO |
Emodin results in increased expression of FADD mRNA |
CTD |
PMID:21319176 |
|
NCBI chr 1:199,743,200...199,745,746
Ensembl chr 1:199,739,994...199,745,653
|
|
G |
Fas |
Fas cell surface death receptor |
multiple interactions decreases expression increases expression |
ISO EXP |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Emodin results in increased expression of FAS protein]; U 0126 promotes the reaction [Emodin results in increased expression of FAS protein] Emodin results in decreased expression of FAS protein |
CTD |
PMID:19549930 PMID:27032576 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Faslg |
Fas ligand |
multiple interactions increases expression |
ISO |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Emodin results in increased expression of FASLG protein]; SB 203580 promotes the reaction [Emodin results in increased expression of FASLG protein]; U 0126 promotes the reaction [Emodin results in increased expression of FASLG protein] |
CTD |
PMID:27032576 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Fn1 |
fibronectin 1 |
decreases expression |
EXP |
Emodin results in decreased expression of FN1 mRNA |
CTD |
PMID:15288473 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Foxo1 |
forkhead box O1 |
increases expression |
ISO |
Emodin results in increased expression of FOXO1 mRNA |
CTD |
PMID:16045814 |
|
NCBI chr 2:136,312,168...136,390,603
Ensembl chr 2:136,312,168...136,387,790
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
multiple interactions |
ISO |
Emodin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of GADD45A mRNA] |
CTD |
PMID:30517764 |
|
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
|
|
G |
Gas2 |
growth arrest-specific 2 |
increases expression |
ISO |
Emodin results in increased expression of GAS2 mRNA |
CTD |
PMID:16045814 |
|
NCBI chr 1:101,452,361...101,582,619
Ensembl chr 1:101,482,591...101,582,619
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
increases expression |
EXP |
Emodin results in increased expression of GCLC mRNA |
CTD |
PMID:34971761 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
increases expression |
EXP |
Emodin results in increased expression of GCLM mRNA |
CTD |
PMID:34971761 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gcnt2 |
glucosaminyl (N-acetyl) transferase 2 |
increases expression |
ISO |
Emodin results in increased expression of GCNT2 mRNA |
CTD |
PMID:15612046 |
|
NCBI chr17:23,796,859...23,901,625
Ensembl chr17:23,796,859...23,901,611
|
|
G |
Gfap |
glial fibrillary acidic protein |
multiple interactions |
EXP |
Emodin inhibits the reaction [Oxaliplatin results in increased expression of GFAP protein]; Emodin inhibits the reaction [TNF protein results in increased expression of GFAP protein] |
CTD |
PMID:36184831 |
|
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
|
|
G |
Golga3 |
golgin A3 |
increases expression |
ISO |
Emodin results in increased expression of GOLGA3 mRNA |
CTD |
PMID:21319176 |
|
NCBI chr12:46,452,409...46,500,509
Ensembl chr12:46,454,870...46,500,509 Ensembl chr 4:46,454,870...46,500,509
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions |
ISO |
[Emodin co-treated with 1-aminobenzotriazole] results in increased expression of GPT protein; Emodin inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of GPT protein] |
CTD |
PMID:34492313 PMID:37023836 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
increases expression |
ISO |
Emodin results in increased expression of GPX1 mRNA |
CTD |
PMID:16045814 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gpx2 |
glutathione peroxidase 2 |
multiple interactions |
ISO |
Emodin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of GPX2 mRNA] |
CTD |
PMID:30517764 |
|
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
decreases expression multiple interactions |
ISO EXP |
Emodin results in decreased expression of GPX4 mRNA; Emodin results in decreased expression of GPX4 protein 2-tert-butylhydroquinone inhibits the reaction [Emodin results in decreased expression of GPX4 mRNA]; 2-tert-butylhydroquinone inhibits the reaction [Emodin results in decreased expression of GPX4 protein]; AKT activator SC79 inhibits the reaction [Emodin results in decreased expression of GPX4 mRNA]; AKT activator SC79 inhibits the reaction [Emodin results in decreased expression of GPX4 protein]; JAG1 protein inhibits the reaction [Emodin results in decreased expression of GPX4 mRNA]; JAG1 protein inhibits the reaction [Emodin results in decreased expression of GPX4 protein] |
CTD |
PMID:37393915 |
|
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions |
ISO |
Emodin promotes the reaction [Cisplatin results in decreased activity of GSR protein] |
CTD |
PMID:22271272 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gstm5 |
glutathione S-transferase, mu 5 |
decreases expression |
ISO |
Emodin results in decreased expression of GSTM3 mRNA |
CTD |
PMID:16045814 |
|
NCBI chr 2:195,531,599...195,534,562
Ensembl chr 2:195,531,495...195,534,553
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
multiple interactions |
ISO |
Emodin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of GSTP1 mRNA]; Emodin inhibits the reaction [TNF protein results in increased expression of GSTP1 mRNA] |
CTD |
PMID:15313406 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
H2ax |
H2A.X variant histone |
increases expression multiple interactions |
ISO |
Emodin results in increased expression of H2AX protein; Emodin results in increased expression of H2AX protein modified form TOP2A affects the reaction [Emodin results in increased expression of H2AX protein modified form] |
CTD |
PMID:20855424 PMID:34492313 PMID:36893906 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
|
|
G |
Hacd3 |
3-hydroxyacyl-CoA dehydratase 3 |
decreases expression |
ISO |
Emodin results in decreased expression of HACD3 mRNA |
CTD |
PMID:16045814 |
|
NCBI chr 8:65,501,240...65,538,507
Ensembl chr 8:65,501,240...65,538,507
|
|
G |
Hes1 |
hes family bHLH transcription factor 1 |
decreases expression multiple interactions |
ISO EXP |
Emodin results in decreased expression of HES1 mRNA; Emodin results in decreased expression of HES1 protein JAG1 protein inhibits the reaction [Emodin results in decreased expression of HES1 mRNA]; JAG1 protein inhibits the reaction [Emodin results in decreased expression of HES1 protein] |
CTD |
PMID:37393915 |
|
NCBI chr11:70,705,763...70,708,176
Ensembl chr11:70,705,764...70,708,192
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
multiple interactions |
ISO |
Emodin inhibits the reaction [Oxygen deficiency results in decreased expression of HIF1A mRNA] |
CTD |
PMID:21382473 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hils1 |
histone linker H1 domain, spermatid-specific 1 |
increases expression |
ISO |
Emodin results in increased expression of H1F9 mRNA |
CTD |
PMID:21319176 |
|
NCBI chr10:79,913,525...79,914,321
Ensembl chr10:79,913,480...79,914,321
|
|
G |
Hk2 |
hexokinase 2 |
increases expression |
ISO |
Emodin results in increased expression of HK2 mRNA |
CTD |
PMID:21319176 |
|
NCBI chr 4:115,234,509...115,283,530
Ensembl chr 4:115,234,509...115,283,530
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions decreases expression increases expression |
ISO EXP |
Emodin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of HMOX1 mRNA]; Emodin promotes the reaction [Tobacco Smoke Pollution results in increased expression of HMOX1 mRNA]; Emodin promotes the reaction [Tobacco Smoke Pollution results in increased expression of HMOX1 protein] Emodin results in decreased expression of HMOX1 mRNA; Emodin results in decreased expression of HMOX1 protein 2-tert-butylhydroquinone inhibits the reaction [Emodin results in decreased expression of HMOX1 mRNA]; 2-tert-butylhydroquinone inhibits the reaction [Emodin results in decreased expression of HMOX1 protein]; AKT activator SC79 inhibits the reaction [Emodin results in decreased expression of HMOX1 mRNA]; AKT activator SC79 inhibits the reaction [Emodin results in decreased expression of HMOX1 protein]; JAG1 protein inhibits the reaction [Emodin results in decreased expression of HMOX1 mRNA]; JAG1 protein inhibits the reaction [Emodin results in decreased expression of HMOX1 protein] Emodin results in increased expression of HMOX1 mRNA |
CTD |
PMID:26139382 PMID:30517764 PMID:34875353 PMID:37393915 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
decreases expression affects glucuronidation |
EXP ISO |
Emodin results in decreased expression of HNF4A protein Emodin results in decreased expression of HNF4A mRNA; Emodin results in decreased expression of HNF4A protein HNF4A gene SNP affects the glucuronidation of Emodin |
CTD |
PMID:32538071 |
|
NCBI chr 3:152,186,787...152,248,320
Ensembl chr 3:152,186,787...152,248,320
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
increases expression |
EXP |
Emodin results in increased expression of HSPA5 protein |
CTD |
PMID:19549930 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions |
EXP |
Emodin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of ICAM1 protein] |
CTD |
PMID:18590720 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Igsf11 |
immunoglobulin superfamily, member 11 |
increases expression |
ISO |
Emodin results in increased expression of IGSF11 mRNA |
CTD |
PMID:21319176 |
|
NCBI chr11:61,733,139...61,884,059
Ensembl chr11:61,733,144...61,868,348
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
ISO |
Emodin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of IL10 mRNA] |
CTD |
PMID:30517764 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il13 |
interleukin 13 |
multiple interactions |
ISO |
Emodin inhibits the reaction [Ovalbumin results in increased secretion of IL13 protein] |
CTD |
PMID:22484343 |
|
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
|
|
G |
Il15 |
interleukin 15 |
increases expression |
ISO |
Emodin results in increased expression of IL15 mRNA |
CTD |
PMID:15612046 |
|
NCBI chr19:25,640,025...25,706,818
Ensembl chr19:25,640,251...25,706,820
|
|
G |
Il18 |
interleukin 18 |
multiple interactions |
ISO |
Emodin inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of IL18 protein] |
CTD |
PMID:37023836 |
|
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO EXP |
Emodin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of IL1B mRNA]; Emodin inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of IL1B mRNA]; Emodin inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of IL1B protein]; Emodin inhibits the reaction [Tobacco Smoke Pollution results in increased secretion of IL1B protein] Emodin inhibits the reaction [Oxaliplatin results in increased expression of IL1B protein]; Emodin inhibits the reaction [TNF protein results in increased expression of IL1B protein] |
CTD |
PMID:26139382 PMID:30517764 PMID:36184831 PMID:37023836 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il4 |
interleukin 4 |
multiple interactions |
ISO |
Emodin inhibits the reaction [Ovalbumin results in increased secretion of IL4 protein] |
CTD |
PMID:22484343 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il5 |
interleukin 5 |
multiple interactions |
ISO |
Emodin inhibits the reaction [Ovalbumin results in increased secretion of IL5 protein] |
CTD |
PMID:22484343 |
|
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
EXP ISO |
Emodin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of IL6 protein] Emodin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of IL6 mRNA]; Emodin inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of IL6 protein]; Emodin inhibits the reaction [Tobacco Smoke Pollution results in increased secretion of IL6 protein] Emodin inhibits the reaction [IL6 protein results in increased phosphorylation of AKT1 protein]; Emodin inhibits the reaction [IL6 protein results in increased phosphorylation of JAK1 protein]; Emodin inhibits the reaction [IL6 protein results in increased phosphorylation of JAK2 protein]; Emodin inhibits the reaction [IL6 protein results in increased phosphorylation of STAT3 protein] |
CTD |
PMID:18590720 PMID:23848338 PMID:26139382 PMID:30517764 PMID:37023836 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Itpr1 |
inositol 1,4,5-trisphosphate receptor, type 1 |
decreases expression |
ISO |
Emodin results in decreased expression of ITPR1 mRNA |
CTD |
PMID:16045814 |
|
NCBI chr 4:141,187,377...141,554,240
Ensembl chr 4:141,187,418...141,510,491
|
|
G |
Jag1 |
jagged canonical Notch ligand 1 |
multiple interactions decreases expression |
EXP |
2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine promotes the reaction [Emodin inhibits the reaction [TGFB1 protein results in increased expression of JAG1 protein]]; Emodin inhibits the reaction [TGFB1 protein results in increased expression of JAG1 protein]; JAG1 protein inhibits the reaction [Emodin results in decreased expression of and results in decreased cleavage of NOTCH1 protein]; JAG1 protein inhibits the reaction [Emodin results in decreased expression of and results in decreased localization of NFE2L2 protein]; JAG1 protein inhibits the reaction [Emodin results in decreased expression of GPX4 mRNA]; JAG1 protein inhibits the reaction [Emodin results in decreased expression of GPX4 protein]; JAG1 protein inhibits the reaction [Emodin results in decreased expression of HES1 mRNA]; JAG1 protein inhibits the reaction [Emodin results in decreased expression of HES1 protein]; JAG1 protein inhibits the reaction [Emodin results in decreased expression of HMOX1 mRNA]; JAG1 protein inhibits the reaction [Emodin results in decreased expression of HMOX1 protein]; JAG1 protein inhibits the reaction [Emodin results in decreased expression of NFE2L2 mRNA]; JAG1 protein inhibits the reaction [Emodin results in decreased expression of NQO1 mRNA]; JAG1 protein inhibits the reaction [Emodin results in decreased expression of NQO1 protein]; JAG1 protein inhibits the reaction [Emodin results in increased expression of PTGS2 mRNA]; JAG1 protein inhibits the reaction [Emodin results in increased expression of TP53 protein] Emodin results in decreased expression of JAG1 protein |
CTD |
PMID:27989784 PMID:37393915 |
|
NCBI chr 3:124,406,783...124,442,220
Ensembl chr 3:124,406,794...124,442,209
|
|
G |
Jak1 |
Janus kinase 1 |
decreases phosphorylation multiple interactions |
ISO |
Emodin results in decreased phosphorylation of JAK1 protein Emodin inhibits the reaction [IL6 protein results in increased phosphorylation of JAK1 protein] |
CTD |
PMID:23848338 |
|
NCBI chr 5:115,780,248...115,888,841
Ensembl chr 5:115,780,248...115,888,926
|
|
G |
Jak2 |
Janus kinase 2 |
decreases phosphorylation multiple interactions |
ISO |
Emodin results in decreased phosphorylation of JAK2 protein Emodin inhibits the reaction [IL6 protein results in increased phosphorylation of JAK2 protein] |
CTD |
PMID:23848338 |
|
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
|
|
G |
Jund |
JunD proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
[arsenic trioxide co-treated with IFNA2 protein co-treated with Docosahexaenoic Acids co-treated with Emodin] results in decreased expression of JUND protein |
CTD |
PMID:17077332 |
|
NCBI chr16:18,734,121...18,735,799
Ensembl chr16:18,734,122...18,735,799
|
|
G |
Krt19 |
keratin 19 |
decreases expression |
ISO |
Emodin results in decreased expression of KRT19 mRNA |
CTD |
PMID:16045814 |
|
NCBI chr10:85,075,835...85,080,552
Ensembl chr10:85,066,802...85,171,799
|
|
G |
Laptm5 |
lysosomal protein transmembrane 5 |
increases expression |
ISO |
Emodin results in increased expression of LAPTM5 mRNA |
CTD |
PMID:15612046 |
|
NCBI chr 5:143,087,759...143,109,807
Ensembl chr 5:143,087,759...143,109,807
|
|
G |
Lef1 |
lymphoid enhancer binding factor 1 |
decreases expression |
ISO |
Emodin results in decreased expression of LEF1 mRNA |
CTD |
PMID:15612046 |
|
NCBI chr 2:219,666,549...219,779,815
Ensembl chr 2:219,666,592...219,779,794
|
|
G |
Lrp1 |
LDL receptor related protein 1 |
multiple interactions |
ISO |
[Emodin co-treated with cobaltous chloride] results in increased expression of LRP1 protein |
CTD |
PMID:23212659 |
|
NCBI chr 7:63,380,325...63,461,029
Ensembl chr 7:63,380,356...63,460,910
|
|
G |
Macf1 |
microtubule-actin crosslinking factor 1 |
decreases expression |
ISO |
Emodin results in decreased expression of MACF1 mRNA |
CTD |
PMID:16045814 |
|
NCBI chr 5:135,623,734...135,949,097
Ensembl chr 5:135,623,742...135,945,905
|
|
G |
Maob |
monoamine oxidase B |
decreases activity |
EXP |
Emodin results in decreased activity of MAOB protein |
CTD |
PMID:15120460 |
|
NCBI chr X:5,907,327...6,010,996
Ensembl chr X:5,907,266...6,011,003
|
|
G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
multiple interactions |
EXP |
Emodin inhibits the reaction [PDGFB protein results in increased phosphorylation of MAP2K1 protein] |
CTD |
PMID:15288473 |
|
NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147
|
|
G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
multiple interactions |
EXP |
Emodin inhibits the reaction [PDGFB protein results in increased phosphorylation of MAP2K2 protein] |
CTD |
PMID:15288473 |
|
NCBI chr 7:8,590,729...8,610,279
Ensembl chr 7:8,580,905...8,610,243
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions decreases phosphorylation increases phosphorylation |
EXP ISO |
Emodin inhibits the reaction [PDGFB protein results in increased phosphorylation of MAPK1 protein] Emodin results in decreased phosphorylation of MAPK1 protein Emodin results in increased phosphorylation of MAPK1 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Emodin results in increased phosphorylation of MAPK1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Emodin results in decreased phosphorylation of MAPK1 protein]; [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one co-treated with T0901317] inhibits the reaction [Emodin results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:15288473 PMID:26972667 PMID:27032576 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk10 |
mitogen activated protein kinase 10 |
increases expression |
ISO |
Emodin results in increased expression of MAPK10 mRNA |
CTD |
PMID:15612046 |
|
NCBI chr14:6,497,662...6,790,109
Ensembl chr14:6,497,707...6,786,201
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [Emodin promotes the reaction [arsenic trioxide results in increased phosphorylation of and results in increased activity of MAPK14 protein]]; Emodin promotes the reaction [arsenic trioxide results in increased phosphorylation of and results in increased activity of MAPK14 protein] |
CTD |
PMID:14729614 |
|
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions decreases phosphorylation increases phosphorylation |
EXP ISO |
Emodin inhibits the reaction [PDGFB protein results in increased phosphorylation of MAPK3 protein] Emodin results in decreased phosphorylation of MAPK3 protein Emodin results in increased phosphorylation of MAPK3 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Emodin results in increased phosphorylation of MAPK3 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Emodin results in decreased phosphorylation of MAPK3 protein]; [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one co-treated with T0901317] inhibits the reaction [Emodin results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:15288473 PMID:26972667 PMID:27032576 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapt |
microtubule-associated protein tau |
decreases expression |
ISO |
Emodin results in decreased expression of MAPT mRNA |
CTD |
PMID:16045814 |
|
NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
|
|
G |
Mcl1 |
MCL1 apoptosis regulator, BCL2 family member |
decreases expression increases expression |
ISO |
Emodin results in decreased expression of MCL1 mRNA; Emodin results in decreased expression of MCL1 protein Emodin results in increased expression of MCL1 mRNA |
CTD |
PMID:21319176 PMID:23848338 |
|
NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303
|
|
G |
Melk |
maternal embryonic leucine zipper kinase |
decreases expression |
ISO |
Emodin results in decreased expression of MELK mRNA; Emodin results in decreased expression of MELK protein |
CTD |
PMID:36893906 |
|
NCBI chr 5:58,540,393...58,600,562
Ensembl chr 5:58,540,449...58,600,937
|
|
G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
increases expression |
EXP |
Emodin results in increased expression of MGMT mRNA |
CTD |
PMID:19549930 |
|
NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756
|
|
G |
Mitf |
melanocyte inducing transcription factor |
decreases expression |
ISO |
Emodin results in decreased expression of MITF protein |
CTD |
PMID:26972667 |
|
NCBI chr 4:130,409,020...130,621,145
Ensembl chr 4:130,409,217...130,621,145
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
EXP |
Emodin inhibits the reaction [1-Naphthylisothiocyanate results in increased activity of MPO protein] |
CTD |
PMID:18590720 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Muc5ac |
mucin 5AC, oligomeric mucus/gel-forming |
multiple interactions |
ISO |
Emodin inhibits the reaction [Ovalbumin results in increased expression of MUC5AC mRNA] |
CTD |
PMID:22484343 |
|
NCBI chr 1:196,864,336...196,896,475
Ensembl chr 1:196,864,336...196,896,475
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
multiple interactions affects expression |
EXP |
Emodin inhibits the reaction [AGT protein results in increased expression of MYC protein] Emodin affects the expression of MYC protein |
CTD |
PMID:17886230 PMID:19549930 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Mylk |
myosin light chain kinase |
increases activity |
EXP |
Emodin results in increased activity of MYLK protein |
CTD |
PMID:15133857 |
|
NCBI chr11:65,783,008...66,030,239
Ensembl chr11:65,783,008...66,030,261
|
|
G |
Ncoa2 |
nuclear receptor coactivator 2 |
increases expression |
ISO |
Emodin results in increased expression of NCOA2 mRNA |
CTD |
PMID:21319176 |
|
NCBI chr 5:5,835,642...6,069,693
Ensembl chr 5:5,835,706...6,067,451
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions decreases expression affects localization |
ISO EXP |
Emodin promotes the reaction [Tobacco Smoke Pollution results in increased expression of and results in increased activity of NFE2L2 protein]; Emodin promotes the reaction [Tobacco Smoke Pollution results in increased expression of NFE2L2 mRNA]; Emodin results in decreased expression of and results in decreased localization of NFE2L2 protein Emodin results in decreased expression of NFE2L2 mRNA Emodin affects the localization of NFE2L2 protein 2-tert-butylhydroquinone inhibits the reaction [Emodin results in decreased expression of and results in decreased localization of NFE2L2 protein]; 2-tert-butylhydroquinone inhibits the reaction [Emodin results in decreased expression of NFE2L2 mRNA]; [[Emodin inhibits the reaction [PKM protein binds to PKM protein binds to PKM protein binds to PKM protein]] results in increased abundance of [PKM protein binds to PKM protein]] which binds to NFE2L2 protein; AKT activator SC79 inhibits the reaction [Emodin results in decreased expression of and results in decreased localization of NFE2L2 protein]; Emodin affects the localization of [PKM protein binds to NFE2L2 protein]; Emodin promotes the reaction [PKM protein binds to NFE2L2 protein]; Emodin results in decreased expression of and results in decreased localization of NFE2L2 protein; JAG1 protein inhibits the reaction [Emodin results in decreased expression of and results in decreased localization of NFE2L2 protein]; JAG1 protein inhibits the reaction [Emodin results in decreased expression of NFE2L2 mRNA] |
CTD |
PMID:26139382 PMID:34971761 PMID:37393915 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
increases expression multiple interactions |
EXP ISO |
Emodin results in increased expression of NFKB1 protein Emodin inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of NFKB1 mRNA] |
CTD |
PMID:19549930 PMID:37023836 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
increases expression multiple interactions |
ISO |
Emodin results in increased expression of NFKBIA mRNA Emodin inhibits the reaction [Ovalbumin results in increased phosphorylation of and results in increased degradation of NFKBIA protein] |
CTD |
PMID:16045814 PMID:22484343 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nkx6-2 |
NK6 homeobox 2 |
increases expression |
ISO |
Emodin results in increased expression of NKX6-2 mRNA |
CTD |
PMID:15612046 |
|
NCBI chr 1:194,380,149...194,383,533
Ensembl chr 1:194,381,975...194,383,515
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
multiple interactions |
ISO |
Emodin inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of NLRP3 mRNA] |
CTD |
PMID:37023836 |
|
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions affects expression |
EXP |
Emodin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of NOS2 protein] Emodin affects the expression of NOS2 |
CTD |
PMID:18590720 PMID:23615023 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Notch1 |
notch receptor 1 |
decreases expression multiple interactions decreases response to substance |
EXP ISO |
Emodin results in decreased expression of NOTCH1 protein Emodin results in decreased expression of and results in decreased cleavage of NOTCH1 protein 2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine promotes the reaction [Emodin inhibits the reaction [TGFB1 protein results in increased expression of NOTCH1 protein]]; Emodin inhibits the reaction [TGFB1 protein results in increased expression of and affects the localization of NOTCH1 protein]; Emodin results in decreased expression of and results in decreased cleavage of NOTCH1 protein; JAG1 protein inhibits the reaction [Emodin results in decreased expression of and results in decreased cleavage of NOTCH1 protein]; NOTCH1 protein inhibits the reaction [Emodin inhibits the reaction [TGFB1 protein results in decreased expression of CDH1 protein]]; NOTCH1 protein inhibits the reaction [Emodin inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]]; NOTCH1 protein inhibits the reaction [Emodin inhibits the reaction [TGFB1 protein results in increased expression of VIM protein]]; NOTCH1 protein inhibits the reaction [Emodin results in decreased activity of TGFB1 protein] NOTCH1 protein results in decreased susceptibility to Emodin |
CTD |
PMID:27989784 PMID:37393915 |
|
NCBI chr 3:9,277,955...9,323,531
Ensembl chr 3:9,278,086...9,323,531
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression decreases expression multiple interactions |
ISO EXP |
Emodin results in increased expression of NQO1 mRNA Emodin results in decreased expression of NQO1 mRNA; Emodin results in decreased expression of NQO1 protein 2-tert-butylhydroquinone inhibits the reaction [Emodin results in decreased expression of NQO1 mRNA]; 2-tert-butylhydroquinone inhibits the reaction [Emodin results in decreased expression of NQO1 protein]; AKT activator SC79 inhibits the reaction [Emodin results in decreased expression of NQO1 mRNA]; AKT activator SC79 inhibits the reaction [Emodin results in decreased expression of NQO1 protein]; Emodin results in increased expression of and results in increased activity of NQO1 protein; JAG1 protein inhibits the reaction [Emodin results in decreased expression of NQO1 mRNA]; JAG1 protein inhibits the reaction [Emodin results in decreased expression of NQO1 protein] |
CTD |
PMID:34875353 PMID:34971761 PMID:37393915 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
increases expression |
ISO |
Emodin results in increased expression of NR0B2 mRNA |
CTD |
PMID:30517764 |
|
NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
|
|
G |
Nr1h3 |
nuclear receptor subfamily 1, group H, member 3 |
increases expression |
ISO |
Emodin results in increased expression of NR1H3 mRNA; Emodin results in increased expression of NR1H3 protein |
CTD |
PMID:26972667 |
|
NCBI chr 3:77,158,808...77,168,907
Ensembl chr 3:77,158,808...77,168,722
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
decreases expression |
ISO |
Emodin results in decreased expression of NR1H4 mRNA; Emodin results in decreased expression of NR1H4 protein |
CTD |
PMID:30517764 |
|
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
|
|
G |
Oma1 |
OMA1 zinc metallopeptidase |
multiple interactions |
EXP |
Emodin inhibits the reaction [Hydrogen Peroxide results in increased expression of OMA1 protein]; Emodin inhibits the reaction [Oxidopamine results in increased expression of OMA1 protein] |
CTD |
PMID:34971761 |
|
NCBI chr 5:118,083,728...118,136,980
Ensembl chr 5:118,083,728...118,136,980
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
increases activity increases cleavage multiple interactions |
ISO |
Emodin results in increased activity of PARP1 protein Emodin results in increased cleavage of PARP1 protein 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Emodin results in increased cleavage of PARP1 protein]; [U 0126 co-treated with Emodin] results in increased cleavage of PARP1 protein; SB 203580 inhibits the reaction [Emodin results in increased cleavage of PARP1 protein]; U 0126 inhibits the reaction [Emodin results in increased cleavage of PARP1 protein] |
CTD |
PMID:23848338 PMID:27032576 PMID:34492313 PMID:36893906 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions |
EXP |
Emodin inhibits the reaction [AGT protein results in increased expression of PCNA protein] |
CTD |
PMID:17886230 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pdcl |
phosducin like |
decreases expression |
ISO |
Emodin results in decreased expression of PDCL mRNA |
CTD |
PMID:16045814 |
|
NCBI chr 3:21,110,165...21,119,763
Ensembl chr 3:21,110,167...21,119,715 Ensembl chr 3:21,110,167...21,119,715
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
multiple interactions |
EXP |
Emodin inhibits the reaction [PDGFB protein results in increased phosphorylation of AKT1 protein]; Emodin inhibits the reaction [PDGFB protein results in increased phosphorylation of MAP2K1 protein]; Emodin inhibits the reaction [PDGFB protein results in increased phosphorylation of MAP2K2 protein]; Emodin inhibits the reaction [PDGFB protein results in increased phosphorylation of MAPK1 protein]; Emodin inhibits the reaction [PDGFB protein results in increased phosphorylation of MAPK3 protein]; Emodin inhibits the reaction [PDGFB protein results in increased phosphorylation of PDGFRB protein]; Emodin inhibits the reaction [PDGFB protein results in increased phosphorylation of RAF1 protein] |
CTD |
PMID:15288473 |
|
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
|
|
G |
Pdgfrb |
platelet derived growth factor receptor beta |
multiple interactions decreases expression |
EXP |
Emodin inhibits the reaction [PDGFB protein results in increased phosphorylation of PDGFRB protein] Emodin results in decreased expression of PDGFRB protein |
CTD |
PMID:15288473 |
|
NCBI chr18:54,499,962...54,538,840
Ensembl chr18:54,499,964...54,538,843
|
|
G |
Pecam1 |
platelet and endothelial cell adhesion molecule 1 |
decreases expression |
ISO |
Emodin results in decreased expression of PECAM1 protein |
CTD |
PMID:23848338 |
|
NCBI chr10:91,590,521...91,652,279
Ensembl chr10:91,590,521...91,652,116
|
|
G |
Pik3c3 |
phosphatidylinositol 3-kinase, catalytic subunit type 3 |
increases expression |
ISO |
Emodin results in increased expression of PIK3C3 mRNA |
CTD |
PMID:16045814 |
|
NCBI chr18:21,845,282...21,934,387
Ensembl chr18:21,845,295...21,929,048
|
|
G |
Pik3r1 |
phosphoinositide-3-kinase regulatory subunit 1 |
affects expression |
EXP |
Emodin affects the expression of PIK3R1 protein |
CTD |
PMID:19549930 |
|
NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:32,882,032...32,963,631
|
|
G |
Pkm |
pyruvate kinase M1/2 |
affects localization decreases activity multiple interactions |
EXP |
Emodin affects the localization of PKM protein Emodin results in decreased activity of PKM protein [[Emodin inhibits the reaction [PKM protein binds to PKM protein binds to PKM protein binds to PKM protein]] results in increased abundance of [PKM protein binds to PKM protein]] which binds to NFE2L2 protein; [[Emodin inhibits the reaction [PKM protein binds to PKM protein binds to PKM protein binds to PKM protein]] results in increased abundance of [PKM protein binds to PKM protein]] which results in decreased activity of PKM protein; [Emodin inhibits the reaction [PKM protein binds to PKM protein binds to PKM protein binds to PKM protein]] results in increased abundance of [PKM protein binds to PKM protein]; Emodin affects the localization of [PKM protein binds to NFE2L2 protein]; Emodin inhibits the reaction [PKM protein binds to PKM protein binds to PKM protein binds to PKM protein]; Emodin promotes the reaction [PKM protein binds to NFE2L2 protein] |
CTD |
PMID:34971761 |
|
NCBI chr 8:60,057,629...60,079,600
Ensembl chr 8:60,057,402...60,079,599
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
increases expression multiple interactions |
ISO |
Emodin results in increased expression of PPARG protein Emodin results in increased stability of and results in increased expression of PPARG mRNA |
CTD |
PMID:25448808 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ppm1d |
protein phosphatase, Mg2+/Mn2+ dependent, 1D |
increases expression |
ISO |
Emodin results in increased expression of PPM1D mRNA |
CTD |
PMID:16045814 |
|
NCBI chr10:70,172,603...70,208,607
Ensembl chr10:70,172,603...70,208,607
|
|
G |
Ppp1r1c |
protein phosphatase 1, regulatory (inhibitor) subunit 1C |
decreases expression |
ISO |
Emodin results in decreased expression of PPP1R1C mRNA |
CTD |
PMID:15612046 |
|
NCBI chr 3:64,616,700...64,719,696
Ensembl chr 3:64,616,700...64,724,104
|
|
G |
Prdx6 |
peroxiredoxin 6 |
increases expression |
ISO |
Emodin results in increased expression of PRDX6 mRNA |
CTD |
PMID:16045814 |
|
NCBI chr13:73,528,746...73,539,295
Ensembl chr13:73,528,210...73,539,355
|
|
G |
Prkca |
protein kinase C, alpha |
affects localization |
EXP |
Emodin affects the localization of PRKCA protein |
CTD |
PMID:15133857 |
|
NCBI chr10:92,889,390...93,288,013
Ensembl chr10:92,894,012...93,288,012
|
|
G |
Prkcd |
protein kinase C, delta |
decreases expression affects expression |
ISO EXP |
Emodin results in decreased expression of PRKCD mRNA Emodin affects the expression of PRKCD protein |
CTD |
PMID:16045814 PMID:19549930 |
|
NCBI chr16:5,769,217...5,799,380
Ensembl chr16:5,769,215...5,799,352
|
|
G |
Prm3 |
protamine 3 |
increases expression |
ISO |
Emodin results in increased expression of PRM3 mRNA |
CTD |
PMID:21319176 |
|
NCBI chr10:4,877,471...4,877,985
Ensembl chr10:4,877,471...4,877,985
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions increases expression |
EXP ISO |
2-tert-butylhydroquinone inhibits the reaction [Emodin results in increased expression of PTGS2 mRNA]; AKT activator SC79 inhibits the reaction [Emodin results in increased expression of PTGS2 mRNA]; Emodin inhibits the reaction [Oxaliplatin results in increased expression of PTGS2 protein]; Emodin inhibits the reaction [TNF protein results in increased expression of PTGS2 protein]; JAG1 protein inhibits the reaction [Emodin results in increased expression of PTGS2 mRNA] Emodin results in increased expression of PTGS2 mRNA; Emodin results in increased expression of PTGS2 protein |
CTD |
PMID:36184831 PMID:37393915 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ptk2 |
protein tyrosine kinase 2 |
affects expression |
EXP |
Emodin affects the expression of PTK2 protein |
CTD |
PMID:19549930 |
|
NCBI chr 7:105,126,725...105,331,848
Ensembl chr 7:105,126,728...105,331,783
|
|
G |
Ptpn6 |
protein tyrosine phosphatase, non-receptor type 6 |
increases expression multiple interactions |
ISO |
Emodin results in increased expression of PTPN6 protein PTPN6 mutant form inhibits the reaction [Emodin results in decreased phosphorylation of and results in decreased activity of STAT3 protein] |
CTD |
PMID:23848338 |
|
NCBI chr 4:157,526,034...157,550,783
Ensembl chr 4:157,526,035...157,550,984
|
|
G |
Raf1 |
Raf-1 proto-oncogene, serine/threonine kinase |
decreases expression multiple interactions |
ISO EXP |
Emodin results in decreased expression of RAF1 mRNA Emodin inhibits the reaction [PDGFB protein results in increased phosphorylation of RAF1 protein] |
CTD |
PMID:15288473 PMID:16045814 |
|
NCBI chr 4:148,679,534...148,740,265
Ensembl chr 4:148,679,530...148,740,317
|
|
G |
Rag1 |
recombination activating 1 |
decreases expression |
ISO |
Emodin results in decreased expression of RAG1 mRNA |
CTD |
PMID:15612046 |
|
NCBI chr 3:87,917,061...87,928,158
Ensembl chr 3:87,917,004...87,928,291
|
|
G |
Rarb |
retinoic acid receptor, beta |
decreases expression |
ISO |
Emodin results in decreased expression of RARB mRNA |
CTD |
PMID:22609528 |
|
NCBI chr15:8,700,533...9,051,288
Ensembl chr15:8,406,492...9,051,288
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
decreases expression |
ISO |
Emodin results in decreased expression of RB1 mRNA |
CTD |
PMID:16045814 |
|
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
|
|
G |
Rcn2 |
reticulocalbin 2 |
increases expression |
ISO |
Emodin results in increased expression of RCN2 mRNA |
CTD |
PMID:16045814 |
|
NCBI chr 8:56,449,206...56,466,253
Ensembl chr 8:56,449,206...56,466,251
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions decreases localization |
EXP ISO |
Emodin affects the expression of and affects the localization of RELA protein; Emodin inhibits the reaction [1-Naphthylisothiocyanate results in increased localization of RELA protein]; Emodin inhibits the reaction [Oxaliplatin results in increased expression of RELA protein]; Emodin inhibits the reaction [TNF protein results in increased expression of RELA protein] Emodin results in decreased localization of RELA protein Emodin inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of RELA protein]; Emodin inhibits the reaction [Ovalbumin affects the localization of RELA protein] |
CTD |
PMID:18590720 PMID:19549930 PMID:22484343 PMID:30517764 PMID:36184831 PMID:37023836 More...
|
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Rhoa |
ras homolog family member A |
decreases expression |
ISO |
Emodin results in decreased expression of RHOA mRNA |
CTD |
PMID:16045814 |
|
NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
|
|
G |
Rock1 |
Rho-associated coiled-coil containing protein kinase 1 |
decreases expression |
ISO |
Emodin results in decreased expression of ROCK1 mRNA |
CTD |
PMID:16045814 |
|
NCBI chr18:1,114,532...1,236,345
Ensembl chr18:1,115,905...1,235,571
|
|
G |
Rock2 |
Rho-associated coiled-coil containing protein kinase 2 |
decreases expression |
ISO |
Emodin results in decreased expression of ROCK2 mRNA |
CTD |
PMID:16045814 |
|
NCBI chr 6:39,679,116...39,774,033
Ensembl chr 6:39,679,082...39,774,031
|
|
G |
Sae1 |
SUMO1 activating enzyme subunit 1 |
decreases expression |
ISO |
Emodin results in decreased expression of SAE1 mRNA |
CTD |
PMID:16045814 |
|
NCBI chr 1:77,030,961...77,086,937
Ensembl chr 1:77,030,965...77,086,986
|
|
G |
Serpine1 |
serpin family E member 1 |
multiple interactions |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [Emodin inhibits the reaction [TNF protein results in increased secretion of SERPINE1 protein]]; Emodin inhibits the reaction [TNF protein results in increased secretion of SERPINE1 protein]; Emodin promotes the reaction [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [TNF protein results in increased secretion of SERPINE1 protein]] |
CTD |
PMID:14534369 |
|
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
|
|
G |
Slc10a1 |
solute carrier family 10 member 1 |
decreases expression multiple interactions |
EXP ISO |
Emodin results in decreased expression of SLC10A1 mRNA; Emodin results in decreased expression of SLC10A1 protein Emodin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of SLC10A1 mRNA] |
CTD |
PMID:28161596 PMID:30517764 |
|
NCBI chr 6:100,613,045...100,626,670
Ensembl chr 6:100,613,045...100,626,670
|
|
G |
Slc22a6 |
solute carrier family 22 member 6 |
decreases activity |
ISO |
Emodin results in decreased activity of SLC22A6 protein |
CTD |
PMID:29045746 |
|
NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173
|
|
G |
Slc22a8 |
solute carrier family 22 member 8 |
decreases activity |
ISO |
Emodin results in decreased activity of SLC22A8 protein |
CTD |
PMID:29045746 |
|
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
|
|
G |
Slco1b2 |
solute carrier organic anion transporter family member 1B2 |
multiple interactions |
ISO |
Emodin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of SLCO1B2 mRNA] |
CTD |
PMID:30517764 |
|
NCBI chr 4:174,551,463...174,619,988
Ensembl chr 4:174,551,480...174,619,981
|
|
G |
Smcp |
sperm mitochondria-associated cysteine-rich protein |
increases expression |
ISO |
Emodin results in increased expression of SMCP mRNA |
CTD |
PMID:21319176 |
|
NCBI chr 2:178,160,948...178,165,951
Ensembl chr 2:178,160,127...178,166,001
|
|
G |
Snu13 |
small nuclear ribonucleoprotein 13 |
decreases expression |
ISO |
Emodin results in decreased expression of SNU13 mRNA |
CTD |
PMID:15612046 |
|
NCBI chr 7:113,565,293...113,570,887
Ensembl chr 7:113,565,295...113,570,872 Ensembl chr 1:113,565,295...113,570,872
|
|
G |
Sod1 |
superoxide dismutase 1 |
multiple interactions |
ISO |
Emodin inhibits the reaction [Oxygen deficiency results in decreased activity of SOD1 protein]; Emodin inhibits the reaction [Oxygen deficiency results in decreased expression of SOD1 mRNA] |
CTD |
PMID:21382473 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
multiple interactions affects activity |
ISO EXP |
Emodin inhibits the reaction [Oxygen deficiency results in decreased activity of SOD2 protein]; Emodin inhibits the reaction [Oxygen deficiency results in decreased expression of SOD2 mRNA] Emodin affects the activity of SOD2 protein |
CTD |
PMID:21382473 PMID:23615023 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Src |
SRC proto-oncogene, non-receptor tyrosine kinase |
decreases phosphorylation |
ISO |
Emodin results in decreased phosphorylation of SRC protein |
CTD |
PMID:23848338 |
|
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
|
|
G |
St8sia1 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 |
increases expression |
ISO |
Emodin results in increased expression of ST8SIA1 mRNA |
CTD |
PMID:16045814 |
|
NCBI chr 4:175,782,989...175,921,338
Ensembl chr 4:175,789,947...175,920,708
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
affects localization multiple interactions |
ISO |
Emodin affects the localization of STAT3 protein Emodin inhibits the reaction [IL6 protein results in increased phosphorylation of STAT3 protein]; Emodin results in decreased phosphorylation of and results in decreased activity of STAT3 protein; pervanadate inhibits the reaction [Emodin results in decreased phosphorylation of and results in decreased activity of STAT3 protein]; PTPN6 mutant form inhibits the reaction [Emodin results in decreased phosphorylation of and results in decreased activity of STAT3 protein] |
CTD |
PMID:23848338 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Stip1 |
stress-induced phosphoprotein 1 |
decreases expression |
ISO |
Emodin results in decreased expression of STIP1 mRNA |
CTD |
PMID:16045814 |
|
NCBI chr 1:204,209,433...204,228,452
Ensembl chr 1:204,178,932...204,228,476
|
|
G |
Sult1a1 |
sulfotransferase family 1A member 1 |
decreases activity |
ISO |
Emodin results in decreased activity of SULT1A1 protein |
CTD |
PMID:27633141 |
|
NCBI chr 1:181,272,022...181,276,750
Ensembl chr 1:181,272,023...181,275,562
|
|
G |
Supt20h |
SPT20 homolog, SAGA complex component |
increases expression |
ISO |
Emodin results in increased expression of SUPT20H mRNA |
CTD |
PMID:16045814 |
|
NCBI chr 2:138,897,316...138,930,493
Ensembl chr 2:138,897,416...138,930,495
|
|
G |
Taok3 |
TAO kinase 3 |
decreases expression |
ISO |
Emodin results in decreased expression of TAOK3 mRNA |
CTD |
PMID:16045814 |
|
NCBI chr12:39,312,354...39,473,656
Ensembl chr12:39,314,027...39,461,244
|
|
G |
Tbcc |
tubulin folding cofactor C |
decreases expression |
ISO |
Emodin results in decreased expression of TBCC mRNA |
CTD |
PMID:16045814 |
|
NCBI chr 9:14,098,855...14,100,043
Ensembl chr 9:14,098,868...14,100,042
|
|
G |
Tcfl5 |
transcription factor like 5 |
increases expression |
ISO |
Emodin results in increased expression of TCFL5 mRNA |
CTD |
PMID:15612046 |
|
NCBI chr 3:167,734,471...167,754,174
Ensembl chr 3:167,734,473...167,754,282
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions decreases activity |
EXP |
2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine promotes the reaction [Emodin inhibits the reaction [TGFB1 protein results in decreased expression of CDH1 protein]]; 2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine promotes the reaction [Emodin inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]]; 2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine promotes the reaction [Emodin inhibits the reaction [TGFB1 protein results in increased expression of JAG1 protein]]; 2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine promotes the reaction [Emodin inhibits the reaction [TGFB1 protein results in increased expression of NOTCH1 protein]]; 2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine promotes the reaction [Emodin inhibits the reaction [TGFB1 protein results in increased expression of VIM protein]]; 2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine promotes the reaction [Emodin results in decreased activity of TGFB1 protein]; Emodin inhibits the reaction [TGFB1 protein results in decreased expression of CDH1 protein]; Emodin inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]; Emodin inhibits the reaction [TGFB1 protein results in increased expression of and affects the localization of NOTCH1 protein]; Emodin inhibits the reaction [TGFB1 protein results in increased expression of COL1A2 mRNA]; Emodin inhibits the reaction [TGFB1 protein results in increased expression of JAG1 protein]; Emodin inhibits the reaction [TGFB1 protein results in increased expression of VIM protein]; Emodin inhibits the reaction [Thioacetamide results in increased expression of TGFB1 mRNA]; NOTCH1 protein inhibits the reaction [Emodin inhibits the reaction [TGFB1 protein results in decreased expression of CDH1 protein]]; NOTCH1 protein inhibits the reaction [Emodin inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]]; NOTCH1 protein inhibits the reaction [Emodin inhibits the reaction [TGFB1 protein results in increased expression of VIM protein]]; NOTCH1 protein inhibits the reaction [Emodin results in decreased activity of TGFB1 protein] |
CTD |
PMID:15288473 PMID:19474275 PMID:27989784 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
EXP ISO |
Emodin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of TNF protein]; Emodin inhibits the reaction [Oxaliplatin results in increased expression of TNF protein]; Emodin inhibits the reaction [TNF protein results in increased expression of GFAP protein]; Emodin inhibits the reaction [TNF protein results in increased expression of IL1B protein]; Emodin inhibits the reaction [TNF protein results in increased expression of PTGS2 protein]; Emodin inhibits the reaction [TNF protein results in increased expression of RELA protein] Emodin inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of TNF mRNA]; Emodin inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of TNF protein]; Emodin inhibits the reaction [Tobacco Smoke Pollution results in increased secretion of TNF protein] 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [Emodin inhibits the reaction [TNF protein results in increased secretion of SERPINE1 protein]]; Emodin inhibits the reaction [TNF protein results in increased expression of GSTP1 mRNA]; Emodin inhibits the reaction [TNF protein results in increased secretion of SERPINE1 protein]; Emodin promotes the reaction [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [TNF protein results in increased secretion of SERPINE1 protein]] |
CTD |
PMID:14534369 PMID:15313406 PMID:18590720 PMID:26139382 PMID:36184831 PMID:37023836 More...
|
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Top2a |
DNA topoisomerase II alpha |
multiple interactions increases activity |
ISO |
Emodin inhibits the reaction [TOP2A results in increased hydrolysis of Adenosine Triphosphate]; TOP2A affects the reaction [Emodin results in increased expression of H2AX protein modified form] Emodin results in increased activity of TOP2A protein |
CTD |
PMID:20855424 |
|
NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874
|
|
G |
Tp53 |
tumor protein p53 |
affects expression multiple interactions increases expression |
EXP ISO |
Emodin affects the expression of TP53 protein 2-tert-butylhydroquinone inhibits the reaction [Emodin results in increased expression of TP53 protein]; AKT activator SC79 inhibits the reaction [Emodin results in increased expression of TP53 protein]; JAG1 protein inhibits the reaction [Emodin results in increased expression of TP53 protein] |
CTD |
PMID:19549930 PMID:37393915 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tp63 |
tumor protein p63 |
increases expression |
ISO |
Emodin results in increased expression of TRP63 mRNA |
CTD |
PMID:15612046 |
|
NCBI chr11:74,838,858...75,049,764
Ensembl chr11:74,838,859...75,049,398
|
|
G |
Traf2 |
Tnf receptor-associated factor 2 |
increases expression decreases expression |
ISO |
Emodin results in increased expression of TRAF2 mRNA Emodin results in decreased expression of TRAF2 mRNA |
CTD |
PMID:16045814 PMID:21319176 |
|
NCBI chr 3:8,341,950...8,366,609
Ensembl chr 3:8,341,951...8,366,538
|
|
G |
Trpv2 |
transient receptor potential cation channel, subfamily V, member 2 |
increases expression |
ISO |
Emodin results in increased expression of TRPV2 mRNA |
CTD |
PMID:15612046 |
|
NCBI chr10:47,265,524...47,294,263
Ensembl chr10:47,272,931...47,294,260
|
|
G |
Tsga13 |
testis specific, 13 |
increases expression |
ISO |
Emodin results in increased expression of TSGA13 mRNA |
CTD |
PMID:21319176 |
|
NCBI chr 4:59,501,773...59,522,925
Ensembl chr 4:59,501,774...59,522,818
|
|
G |
Tubb3 |
tubulin, beta 3 class III |
decreases expression |
ISO |
Emodin results in decreased expression of TUBB3 mRNA |
CTD |
PMID:16045814 |
|
NCBI chr19:51,457,187...51,466,243
Ensembl chr19:51,457,184...51,466,243
|
|
G |
Txn1 |
thioredoxin 1 |
multiple interactions |
EXP |
Emodin results in increased expression of and results in increased activity of TXN protein |
CTD |
PMID:34971761 |
|
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
|
|
G |
Txnl4b |
thioredoxin-like 4B |
decreases expression |
ISO |
Emodin results in decreased expression of TXNL4B mRNA |
CTD |
PMID:16045814 |
|
NCBI chr19:37,530,157...37,539,827
Ensembl chr19:37,530,152...37,538,521
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
decreases expression multiple interactions |
ISO EXP |
Emodin results in decreased expression of TXNRD1 mRNA Emodin results in increased expression of and results in increased activity of TXNRD1 protein |
CTD |
PMID:16045814 PMID:34971761 |
|
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
|
|
G |
Tyr |
tyrosinase |
decreases activity |
ISO |
Emodin results in decreased activity of TYR protein |
CTD |
PMID:26972667 |
|
NCBI chr 1:141,115,036...141,210,207
Ensembl chr 1:141,115,036...141,210,207
|
|
G |
Tyrp1 |
tyrosinase-related protein 1 |
decreases expression |
ISO |
Emodin results in decreased expression of TYRP1 mRNA; Emodin results in decreased expression of TYRP1 protein |
CTD |
PMID:26972667 |
|
NCBI chr 5:95,280,982...95,299,516
Ensembl chr 5:95,280,982...95,299,516
|
|
G |
Ube2i |
ubiquitin-conjugating enzyme E2I |
increases expression |
ISO |
Emodin results in increased expression of UBE2I mRNA |
CTD |
PMID:21319176 |
|
NCBI chr10:14,277,749...14,294,681
Ensembl chr10:69,701,618...69,702,443 Ensembl chr10:69,701,618...69,702,443
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase family 1 member A1 |
increases glucuronidation |
ISO |
UGT1A1 protein results in increased glucuronidation of Emodin |
CTD |
PMID:14557274 |
|
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a9 |
UDP glucuronosyltransferase family 1 member A9 |
increases glucuronidation |
ISO |
UGT1A9 protein results in increased glucuronidation of Emodin |
CTD |
PMID:14557274 PMID:24854283 |
|
NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt2b15 |
UDP glucuronosyltransferase family 2 member B15 |
increases metabolic processing |
EXP |
UGT2B15 protein results in increased metabolism of Emodin |
CTD |
PMID:7574722 |
|
NCBI chr14:20,768,015...20,783,599
Ensembl chr14:20,768,015...20,783,589
|
|
G |
Ugt2b7 |
UDP glucuronosyltransferase family 2 member B7 |
decreases expression |
ISO EXP |
Emodin results in decreased expression of UGT2B7 mRNA; Emodin results in decreased expression of UGT2B7 protein |
CTD |
PMID:32538071 |
|
NCBI chr14:20,896,682...20,919,604
Ensembl chr14:20,896,682...20,919,604
|
|
G |
Vdac1 |
voltage-dependent anion channel 1 |
decreases expression |
ISO |
Emodin results in decreased expression of VDAC1 mRNA |
CTD |
PMID:16045814 |
|
NCBI chr10:36,532,306...36,559,642
Ensembl chr10:36,532,244...36,559,640
|
|
G |
Vegfa |
vascular endothelial growth factor A |
decreases expression |
ISO |
Emodin results in decreased expression of VEGFA mRNA; Emodin results in decreased expression of VEGFA protein |
CTD |
PMID:23848338 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Vim |
vimentin |
decreases expression multiple interactions |
EXP |
Emodin results in decreased expression of VIM protein 2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine promotes the reaction [Emodin inhibits the reaction [TGFB1 protein results in increased expression of VIM protein]]; Emodin inhibits the reaction [TGFB1 protein results in increased expression of VIM protein]; NOTCH1 protein inhibits the reaction [Emodin inhibits the reaction [TGFB1 protein results in increased expression of VIM protein]] |
CTD |
PMID:27989784 |
|
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
|
|
G |
Xrcc1 |
X-ray repair cross complementing 1 |
affects expression |
EXP |
Emodin affects the expression of XRCC1 protein |
CTD |
PMID:19549930 |
|
NCBI chr 1:80,140,495...80,168,705
Ensembl chr 1:80,141,207...80,168,701
|
|
G |
Zfp37 |
zinc finger protein 37 |
increases expression |
ISO |
Emodin results in increased expression of ZFP37 mRNA |
CTD |
PMID:21319176 |
|
NCBI chr 5:75,598,732...75,638,896
Ensembl chr 5:75,598,732...75,638,942
|
|
|
G |
Akr1b10 |
aldo-keto reductase family 1 member B10 |
decreases activity |
ISO |
frangulin A results in decreased activity of AKR1B10 protein |
CTD |
PMID:35065925 |
|
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
|
|
G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
decreases activity |
ISO |
frangulin A results in decreased activity of AKR1C3 protein |
CTD |
PMID:35065925 |
|
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
|
|
G |
Cbr1 |
carbonyl reductase 1 |
decreases activity |
ISO |
frangulin A results in decreased activity of CBR1 protein |
CTD |
PMID:35065925 |
|
NCBI chr11:32,860,571...32,862,981
Ensembl chr11:32,908,950...32,911,393 Ensembl chr11:32,908,950...32,911,393 Ensembl chr11:32,908,950...32,911,393
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions |
ISO |
[frangulin A co-treated with frangulin B] results in decreased activity of CYP1A2 protein |
CTD |
PMID:33438235 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
|
G |
Akr1b10 |
aldo-keto reductase family 1 member B10 |
decreases activity |
ISO |
frangulin B results in decreased activity of AKR1B10 protein |
CTD |
PMID:35065925 |
|
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
|
|
G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
decreases activity |
ISO |
frangulin B results in decreased activity of AKR1C3 protein |
CTD |
PMID:35065925 |
|
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
|
|
G |
Cbr1 |
carbonyl reductase 1 |
decreases activity |
ISO |
frangulin B results in decreased activity of CBR1 protein |
CTD |
PMID:35065925 |
|
NCBI chr11:32,860,571...32,862,981
Ensembl chr11:32,908,950...32,911,393 Ensembl chr11:32,908,950...32,911,393 Ensembl chr11:32,908,950...32,911,393
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions |
ISO |
[frangulin A co-treated with frangulin B] results in decreased activity of CYP1A2 protein |
CTD |
PMID:33438235 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
|
G |
Top2a |
DNA topoisomerase II alpha |
decreases activity |
ISO |
macrosporin results in decreased activity of TOP2A protein |
CTD |
PMID:27682608 |
|
NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874
|
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
increases expression |
EXP |
Maprotiline results in increased expression of ABCB11 mRNA |
CTD |
PMID:27765674 |
|
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
decreases expression |
EXP |
Maprotiline results in decreased expression of ABCC2 mRNA |
CTD |
PMID:27765674 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Becn1 |
beclin 1 |
increases expression |
ISO |
Maprotiline results in increased expression of BECN1 protein |
CTD |
PMID:20503272 |
|
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases activity |
ISO |
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Maprotiline results in increased activity of CASP3 protein] |
CTD |
PMID:23219590 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Kcnh2 |
potassium voltage-gated channel subfamily H member 2 |
multiple interactions |
ISO |
Maprotiline inhibits the reaction [KCNH2 protein results in increased transport of Thallium] |
CTD |
PMID:21158687 |
|
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions increases phosphorylation |
ISO |
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Maprotiline results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:23219590 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions increases phosphorylation |
ISO |
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Maprotiline results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:23219590 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Nos2 |
nitric oxide synthase 2 |
increases expression |
EXP |
Maprotiline results in increased expression of NOS2 mRNA |
CTD |
PMID:12429386 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
multiple interactions |
ISO |
Maprotiline inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] |
CTD |
PMID:21599003 |
|
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
|
|
|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
affects response to substance |
ISO |
ABCA1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
increases expression |
ISO |
Mitoxantrone results in increased expression of ABCB1 protein |
CTD |
PMID:15239124 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 |
affects export affects response to substance increases transport multiple interactions increases export increases expression decreases abundance decreases response to substance increases response to substance affects transport affects uptake |
ISO |
ABCG2 protein affects the export of Mitoxantrone ABCG2 protein affects the susceptibility to Mitoxantrone ABCG2 protein results in increased transport of Mitoxantrone 3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester inhibits the reaction [ABCG2 protein results in increased export of Mitoxantrone]; 3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester inhibits the reaction [ABCG2 protein results in increased transport of Mitoxantrone]; [3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester results in decreased activity of ABCG2 protein] inhibits the reaction [Folic Acid deficiency results in decreased susceptibility to Mitoxantrone]; [3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester results in decreased activity of ABCG2 protein] which results in decreased export of Mitoxantrone; [5-Methoxypsoralen results in decreased activity of ABCG2 protein] which results in decreased export of and results in increased abundance of Mitoxantrone; [ERBB2 results in increased expression of ABCG2] which results in decreased susceptibility to Mitoxantrone; [Folic Acid deficiency results in increased expression of ABCG2 protein] which results in decreased susceptibility to Mitoxantrone; [GSK 1363089 results in decreased activity of ABCG2 protein] which results in decreased export of Mitoxantrone; [Methoxsalen results in decreased activity of ABCG2 protein] which results in decreased export of and results in increased abundance of Mitoxantrone; [MLN 8237 affects the activity of ABCG2 protein] which affects the export of Mitoxantrone; [Novobiocin results in decreased activity of ABCG2 protein] which results in decreased export of Mitoxantrone; ABCG2 gene mutant form results in increased export of and results in decreased susceptibility to Mitoxantrone; ABCG2 mutant form inhibits the reaction [ERBB2 results in decreased susceptibility to Mitoxantrone]; ABCG2 protein results in increased export of and results in decreased susceptibility to Mitoxantrone; Beclomethasone inhibits the reaction [ABCG2 protein results in increased export of Mitoxantrone]; Cadmium Chloride inhibits the reaction [ABCG2 protein results in increased transport of Mitoxantrone]; Chlorpromazine inhibits the reaction [ABCG2 protein results in increased transport of Mitoxantrone]; chrysin inhibits the reaction [ABCG2 protein results in increased secretion of Mitoxantrone]; Clozapine inhibits the reaction [ABCG2 protein results in increased transport of Mitoxantrone]; Cyclosporine inhibits the reaction [ABCG2 protein results in increased export of Mitoxantrone]; Dactinomycin inhibits the reaction [Mitoxantrone results in increased expression of ABCG2 mRNA]; desisobutyrylciclesonide inhibits the reaction [ABCG2 protein results in increased export of Mitoxantrone]; Erlotinib Hydrochloride inhibits the reaction [ABCG2 gene mutant form results in decreased susceptibility to Mitoxantrone]; Erlotinib Hydrochloride inhibits the reaction [ABCG2 protein results in decreased susceptibility to Mitoxantrone]; GSK 1363089 inhibits the reaction [ABCG2 protein results in decreased susceptibility to Mitoxantrone]; Haloperidol inhibits the reaction [ABCG2 protein results in increased transport of Mitoxantrone]; Lapatinib inhibits the reaction [ABCG2 gene mutant form results in increased export of and results in decreased susceptibility to Mitoxantrone]; Lapatinib inhibits the reaction [ABCG2 protein results in increased export of and results in decreased susceptibility to Mitoxantrone]; Mometasone Furoate inhibits the reaction [ABCG2 protein results in increased export of Mitoxantrone]; Novobiocin inhibits the reaction [[5-Methoxypsoralen results in decreased activity of ABCG2 protein] which results in decreased export of and results in increased abundance of Mitoxantrone]; Novobiocin inhibits the reaction [[Methoxsalen results in decreased activity of ABCG2 protein] which results in decreased export of and results in increased abundance of Mitoxantrone]; Olanzapine inhibits the reaction [ABCG2 protein results in increased transport of Mitoxantrone]; oxfendazole inhibits the reaction [ABCG2 protein affects the transport of Mitoxantrone]; Paliperidone Palmitate inhibits the reaction [ABCG2 protein results in increased transport of Mitoxantrone]; Porphyrins inhibits the reaction [ABCG2 protein results in increased export of Mitoxantrone]; Protons promotes the reaction [ABCG2 protein results in decreased susceptibility to Mitoxantrone]; Quetiapine Fumarate inhibits the reaction [ABCG2 protein results in increased transport of Mitoxantrone]; Risperidone inhibits the reaction [ABCG2 protein results in increased transport of Mitoxantrone]; tryptoquivaline inhibits the reaction [ABCG2 gene mutant form results in increased export of and results in decreased susceptibility to Mitoxantrone]; tryptoquivaline inhibits the reaction [ABCG2 protein affects the uptake of Mitoxantrone]; tryptoquivaline inhibits the reaction [ABCG2 protein results in increased export of and results in decreased susceptibility to Mitoxantrone]; tryptoquivaline inhibits the reaction [ABCG2 protein results in increased export of Mitoxantrone] Mitoxantrone results in increased expression of ABCG2 mRNA; Mitoxantrone results in increased expression of ABCG2 protein ABCG2 protein results in decreased abundance of Mitoxantrone ABCG2 protein results in increased susceptibility to Mitoxantrone |
CTD |
PMID:10606239 PMID:12869632 PMID:15239124 PMID:15640379 PMID:15695404 PMID:15703302 PMID:15875186 PMID:16442095 PMID:16636798 PMID:16954373 PMID:17032904 PMID:17093006 PMID:18623116 PMID:18829547 PMID:18834354 PMID:19428349 PMID:20019844 PMID:21712253 PMID:22892056 PMID:24994473 PMID:29079042 PMID:34717915 PMID:34896433 PMID:38367674 More...
|
|
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
|
|
G |
Acadvl |
acyl-CoA dehydrogenase, very long chain |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of ACADVL protein |
CTD |
PMID:34246718 |
|
NCBI chr10:54,732,875...54,738,102
Ensembl chr10:54,732,469...54,738,075
|
|
G |
Acsl3 |
acyl-CoA synthetase long-chain family member 3 |
affects response to substance |
ISO |
ACSL3 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 9:80,115,164...80,164,636
Ensembl chr 9:80,115,112...80,164,627
|
|
G |
Acta1 |
actin, alpha 1, skeletal muscle |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of ACTA1 mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr19:51,883,709...51,886,735
Ensembl chr19:51,883,715...51,886,742
|
|
G |
Actg2 |
actin gamma 2, smooth muscle |
affects response to substance |
ISO |
ACTG2 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 4:116,021,832...116,046,475
Ensembl chr 4:116,021,832...116,046,465
|
|
G |
Adarb1 |
adenosine deaminase, RNA-specific, B1 |
affects response to substance |
ISO |
ADARB1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr20:11,222,569...11,350,854
Ensembl chr20:11,222,583...11,350,852
|
|
G |
Agpat5 |
1-acylglycerol-3-phosphate O-acyltransferase 5 |
affects response to substance |
ISO |
AGPAT5 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr16:70,939,480...70,985,745
Ensembl chr16:70,943,135...70,985,560
|
|
G |
Ahcyl1 |
adenosylhomocysteinase-like 1 |
affects response to substance |
ISO |
AHCYL1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 2:195,294,149...195,328,586
Ensembl chr 2:195,294,153...195,345,815
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
affects response to substance |
ISO |
ALDH2 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
|
|
G |
Amotl1 |
angiomotin-like 1 |
affects response to substance |
ISO |
AMOTL1 mRNA affects the susceptibility to Mitoxantrone |
CTD |
PMID:16044152 |
|
NCBI chr 8:11,348,651...11,467,564
Ensembl chr 8:11,353,674...11,467,573
|
|
G |
Ank2 |
ankyrin 2 |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of ANK2 mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr 2:215,378,028...215,954,015
Ensembl chr 2:215,379,680...215,862,923
|
|
G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
affects response to substance |
ISO |
ASNS protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
|
|
G |
Ass1 |
argininosuccinate synthase 1 |
affects response to substance |
ISO |
ASS1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 3:14,747,355...14,796,909
Ensembl chr 3:14,747,368...14,796,903
|
|
G |
Atg5 |
autophagy related 5 |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of ATG5 protein |
CTD |
PMID:36216988 |
|
NCBI chr20:47,798,217...47,889,216
Ensembl chr20:47,798,290...47,889,209
|
|
G |
Atm |
ATM serine/threonine kinase |
decreases expression increases phosphorylation multiple interactions |
ISO EXP |
Mitoxantrone results in decreased expression of ATM mRNA Mitoxantrone results in increased phosphorylation of ATM protein [Poly(ADP-ribose) Polymerase Inhibitors co-treated with Mitoxantrone] results in increased phosphorylation of ATM protein |
CTD |
PMID:22832221 PMID:29913208 |
|
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
|
|
G |
Atp1a2 |
ATPase Na+/K+ transporting subunit alpha 2 |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of ATP1A2 mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr13:84,729,597...84,754,544
Ensembl chr13:84,729,601...84,754,544
|
|
G |
Atp5f1a |
ATP synthase F1 subunit alpha |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of ATP5F1A protein |
CTD |
PMID:34246718 |
|
NCBI chr18:71,292,406...71,300,342
Ensembl chr18:71,292,374...71,300,794
|
|
G |
Atp5f1b |
ATP synthase F1 subunit beta |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of ATP5F1B protein |
CTD |
PMID:34246718 |
|
NCBI chr 7:515,454...521,858
Ensembl chr 7:515,460...567,273
|
|
G |
Atp5f1c |
ATP synthase F1 subunit gamma |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of ATP5F1C protein |
CTD |
PMID:34246718 |
|
NCBI chr17:68,423,927...68,446,169
Ensembl chr17:68,423,909...68,608,367
|
|
G |
Atp7a |
ATPase copper transporting alpha |
decreases response to substance |
ISO |
ATP7A protein results in decreased susceptibility to Mitoxantrone |
CTD |
PMID:17510416 |
|
NCBI chr X:71,094,144...71,201,550
Ensembl chr X:71,094,202...71,198,354
|
|
G |
Bace2 |
beta-secretase 2 |
affects response to substance |
ISO |
BACE2 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr11:36,707,447...36,789,550
Ensembl chr11:36,707,458...36,789,546
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression |
ISO |
Mitoxantrone results in increased expression of BAX mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bbx |
BBX high mobility group box domain containing |
affects response to substance |
ISO |
BBX protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr11:50,381,249...50,628,934
Ensembl chr11:50,381,247...50,623,251
|
|
G |
Bcam |
basal cell adhesion molecule (Lutheran blood group) |
affects response to substance |
ISO |
BCAM protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 1:79,415,016...79,429,403
Ensembl chr 1:79,415,017...79,429,403
|
|
G |
Bcat1 |
branched chain amino acid transaminase 1 |
increases expression |
EXP |
Mitoxantrone results in increased expression of BCAT1 mRNA |
CTD |
PMID:23558518 |
|
NCBI chr 4:177,964,834...178,046,573
Ensembl chr 4:177,964,834...178,046,597
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions decreases expression |
ISO |
[Cladribine co-treated with Cyclophosphamide co-treated with Mitoxantrone] results in decreased expression of BCL2 protein; BCL2 protein inhibits the reaction [Mitoxantrone results in increased activity of CASP3 protein]; BCL2 protein inhibits the reaction [Mitoxantrone results in increased degradation of PARP1 protein] Mitoxantrone results in decreased expression of BCL2 mRNA |
CTD |
PMID:8219202 PMID:8840993 PMID:15582267 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
multiple interactions |
ISO |
BCL2L1 protein inhibits the reaction [Mitoxantrone results in increased activity of CASP3 protein]; BCL2L1 protein inhibits the reaction [Mitoxantrone results in increased degradation of PARP1 protein] |
CTD |
PMID:8840993 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
|
|
G |
Becn1 |
beclin 1 |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of BECN1 protein |
CTD |
PMID:36216988 |
|
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Birc2 |
baculoviral IAP repeat-containing 2 |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of BIRC2 protein |
CTD |
PMID:15359644 |
|
NCBI chr 8:4,968,856...4,989,325
Ensembl chr 8:4,968,842...4,988,732
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
affects expression increases expression |
ISO |
Mitoxantrone affects the expression of BIRC5 mRNA Mitoxantrone results in increased expression of BIRC5 protein |
CTD |
PMID:16638212 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Bmp7 |
bone morphogenetic protein 7 |
affects response to substance |
ISO |
BMP7 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 3:161,639,915...161,716,938
Ensembl chr 3:161,516,462...161,716,788
|
|
G |
Bst2 |
bone marrow stromal cell antigen 2 |
affects response to substance |
ISO |
BST2 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr16:18,216,605...18,220,979
Ensembl chr16:18,217,407...18,220,979
|
|
G |
Btbd3 |
BTB domain containing 3 |
affects response to substance |
ISO |
BTBD3 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 3:125,591,427...125,621,660
Ensembl chr 3:125,591,490...125,619,038
|
|
G |
Cacna1g |
calcium voltage-gated channel subunit alpha1 G |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of CACNA1G mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr10:79,354,998...79,422,960
Ensembl chr10:79,355,008...79,422,752
|
|
G |
Cacna2d2 |
calcium voltage-gated channel auxiliary subunit alpha2delta 2 |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of CACNA2D2 mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr 8:108,072,208...108,203,516
Ensembl chr 8:108,072,454...108,203,173
|
|
G |
Calr |
calreticulin |
affects localization |
ISO |
Mitoxantrone affects the localization of CALR protein |
CTD |
PMID:20003823 |
|
NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414
|
|
G |
Camk2n1 |
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
affects response to substance |
ISO |
CAMK2N1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 5:150,674,819...150,676,600
Ensembl chr 5:150,673,507...150,676,600
|
|
G |
Casc3 |
CASC3 exon junction complex subunit |
affects response to substance |
ISO |
CASC3 mRNA affects the susceptibility to Mitoxantrone |
CTD |
PMID:16044152 |
|
NCBI chr10:83,769,014...83,788,966
Ensembl chr10:83,769,001...83,788,966
|
|
G |
Casp2 |
caspase 2 |
increases expression increases splicing |
ISO |
Mitoxantrone results in increased expression of CASP2 mRNA alternative form Mitoxantrone results in increased splicing of CASP2 mRNA |
CTD |
PMID:14757846 |
|
NCBI chr 4:71,149,632...71,167,388
Ensembl chr 4:71,149,669...71,167,379
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases activity |
ISO |
BCL2 protein inhibits the reaction [Mitoxantrone results in increased activity of CASP3 protein]; BCL2L1 protein inhibits the reaction [Mitoxantrone results in increased activity of CASP3 protein]; Palmitic Acid promotes the reaction [Mitoxantrone results in increased activity of CASP3 protein] acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [Mitoxantrone results in increased activity of CASP3 protein] |
CTD |
PMID:8840993 PMID:12948851 PMID:16215684 PMID:22700542 PMID:32894303 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp6 |
caspase 6 |
increases activity |
ISO |
Mitoxantrone results in increased activity of CASP6 protein |
CTD |
PMID:12948851 |
|
NCBI chr 2:218,466,063...218,478,503
Ensembl chr 2:218,466,076...218,478,502
|
|
G |
Casp7 |
caspase 7 |
increases activity multiple interactions |
ISO |
Mitoxantrone results in increased activity of CASP7 protein Palmitic Acid promotes the reaction [Mitoxantrone results in increased activity of CASP7 protein] |
CTD |
PMID:12948851 PMID:22700542 |
|
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp8 |
caspase 8 |
increases activity |
ISO |
Mitoxantrone results in increased activity of CASP8 protein |
CTD |
PMID:12948851 PMID:32894303 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
increases activity |
ISO |
Mitoxantrone results in increased activity of CASP9 protein |
CTD |
PMID:12948851 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
decreases activity |
EXP |
Mitoxantrone results in decreased activity of CAT protein |
CTD |
PMID:29913208 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cavin3 |
caveolae associated protein 3 |
affects response to substance |
ISO |
CAVIN3 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 1:159,826,549...159,828,138
Ensembl chr 1:159,826,549...159,828,161
|
|
G |
Cavin4 |
caveolae associated protein 4 |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of CAVIN4 mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr 5:62,996,906...63,007,677
Ensembl chr 5:62,996,865...63,007,678
|
|
G |
Cd55 |
CD55 molecule (Cromer blood group) |
affects response to substance |
ISO |
CD55 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr13:41,857,242...41,885,966
Ensembl chr13:41,857,395...41,885,831
|
|
G |
Celf2 |
CUGBP, Elav-like family member 2 |
affects response to substance |
ISO |
CELF2 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr17:70,904,462...71,729,072
Ensembl chr17:71,210,853...71,728,333
|
|
G |
Cep15 |
centrosomal protein 15 |
affects response to substance |
ISO |
CEP15 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr15:12,815,159...12,835,115
Ensembl chr15:12,818,385...12,833,838
|
|
G |
Ces2h |
carboxylesterase 2H |
affects response to substance |
ISO |
CES2 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr19:32,974,242...32,988,842
Ensembl chr19:32,974,242...32,988,830
|
|
G |
Chrdl1 |
chordin-like 1 |
affects response to substance |
ISO |
CHRDL1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr X:106,889,125...106,992,937
Ensembl chr X:106,889,125...106,992,921
|
|
G |
Cklf |
chemokine-like factor |
affects response to substance |
ISO |
CKLF protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr19:698,097...706,570
Ensembl chr19:698,033...706,570
|
|
G |
Ckm |
creatine kinase, M-type |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of CKM mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr 1:79,061,390...79,071,721
Ensembl chr 1:79,061,456...79,071,720
|
|
G |
Clns1a |
chloride nucleotide-sensitive channel 1A |
affects response to substance |
ISO |
CLNS1A protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 1:152,019,369...152,039,670
Ensembl chr 1:152,019,378...152,039,661
|
|
G |
Clu |
clusterin |
affects response to substance |
ISO |
CLU protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
|
|
G |
Coch |
cochlin |
affects response to substance |
ISO |
COCH protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 6:69,031,139...69,045,124
Ensembl chr 6:69,031,167...69,045,109
|
|
G |
Col11a1 |
collagen type XI alpha 1 chain |
affects response to substance |
ISO |
COL11A1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 2:201,820,715...202,013,853
Ensembl chr 2:201,820,715...202,013,853
|
|
G |
Corin |
corin, serine peptidase |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of CORIN mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr14:35,680,601...35,910,703
Ensembl chr14:35,681,304...35,909,503
|
|
G |
Cpvl |
carboxypeptidase, vitellogenic-like |
affects response to substance |
ISO |
CPVL protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 4:82,981,421...83,091,730
Ensembl chr 4:82,981,422...83,085,655
|
|
G |
Crebl2 |
cAMP responsive element binding protein-like 2 |
affects response to substance |
ISO |
CREBL2 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 4:167,673,359...167,699,299
Ensembl chr 4:167,673,315...167,699,292
|
|
G |
Cs |
citrate synthase |
decreases activity |
ISO |
Mitoxantrone results in decreased activity of CS protein |
CTD |
PMID:34246718 |
|
NCBI chr 7:758,074...791,421
Ensembl chr 7:758,345...791,421
|
|
G |
Csrnp2 |
cysteine and serine rich nuclear protein 2 |
affects response to substance |
ISO |
CSRNP2 mRNA affects the susceptibility to Mitoxantrone |
CTD |
PMID:16044152 |
|
NCBI chr 7:131,594,232...131,610,075
Ensembl chr 7:131,594,232...131,610,075
|
|
G |
Cth |
cystathionine gamma-lyase |
affects response to substance |
ISO |
CTH protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234
|
|
G |
Cxadr |
CXADR, Ig-like cell adhesion molecule |
affects response to substance |
ISO |
CXADR protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr11:16,982,864...17,030,078
Ensembl chr11:16,982,860...17,030,046
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
decreases activity |
ISO |
Mitoxantrone results in decreased activity of CYP1A1 protein |
CTD |
PMID:33814510 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
decreases activity |
ISO |
Mitoxantrone results in decreased activity of CYP1B1 protein |
CTD |
PMID:33814510 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Dapk1 |
death associated protein kinase 1 |
affects response to substance |
ISO |
DAPK1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr17:3,930,223...4,090,991
Ensembl chr17:3,930,213...4,090,991
|
|
G |
Ddit4 |
DNA-damage-inducible transcript 4 |
affects response to substance |
ISO |
DDIT4 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
|
|
G |
Dhrs2 |
dehydrogenase/reductase 2 |
affects response to substance |
ISO |
DHRS2 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr15:28,688,881...28,703,646
Ensembl chr15:28,688,940...28,703,644
|
|
G |
Dis3 |
DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease |
affects response to substance |
ISO |
DIS3 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr15:75,820,040...75,850,450
Ensembl chr15:75,823,436...75,850,642
|
|
G |
Dmd |
dystrophin |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of DMD mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr X:47,272,324...49,504,219
Ensembl chr X:47,272,331...49,504,207
|
|
G |
Dusp4 |
dual specificity phosphatase 4 |
affects response to substance increases expression |
ISO |
DUSP4 protein affects the susceptibility to Mitoxantrone Mitoxantrone results in increased expression of DUSP4 mRNA |
CTD |
PMID:16217747 PMID:26537877 PMID:28940058 |
|
NCBI chr16:57,376,659...57,398,161
Ensembl chr16:57,377,229...57,398,138
|
|
G |
Dyrk2 |
dual specificity tyrosine phosphorylation regulated kinase 2 |
affects response to substance |
ISO |
DYRK2 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 7:54,348,724...54,381,363
Ensembl chr 7:54,349,610...54,380,106
|
|
G |
Egr1 |
early growth response 1 |
affects response to substance |
ISO |
EGR1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Eif2s1 |
eukaryotic translation initiation factor 2 subunit alpha |
affects response to substance |
ISO |
EIF2S1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
|
|
G |
Eif5a |
eukaryotic translation initiation factor 5A |
affects response to substance |
ISO |
EIF5A protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr10:54,640,104...54,644,845
Ensembl chr10:54,640,024...54,644,656
|
|
G |
Elavl4 |
ELAV like RNA binding protein 4 |
affects response to substance |
ISO |
ELAVL4 mRNA affects the susceptibility to Mitoxantrone |
CTD |
PMID:16044152 |
|
NCBI chr 5:125,056,848...125,200,543
Ensembl chr 5:125,056,848...125,200,446
|
|
G |
Elovl5 |
ELOVL fatty acid elongase 5 |
affects response to substance |
ISO |
ELOVL5 mRNA affects the susceptibility to Mitoxantrone |
CTD |
PMID:16044152 |
|
NCBI chr 8:78,790,846...78,857,307
Ensembl chr 8:78,790,846...78,857,284
|
|
G |
En2 |
engrailed homeobox 2 |
affects response to substance |
ISO |
EN2 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 4:7,221,096...7,226,943
Ensembl chr 4:7,221,096...7,226,943
|
|
G |
Enc1 |
ectodermal-neural cortex 1 |
affects response to substance |
ISO |
ENC1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 2:28,550,670...28,562,591
Ensembl chr 2:28,550,464...28,562,713
|
|
G |
Epb41l2 |
erythrocyte membrane protein band 4.1-like 2 |
affects response to substance |
ISO |
EPB41L2 mRNA affects the susceptibility to Mitoxantrone |
CTD |
PMID:16044152 |
|
NCBI chr 1:19,863,010...20,037,795
Ensembl chr 1:19,863,009...20,037,721
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
multiple interactions decreases response to substance |
ISO |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [ERBB2 results in decreased susceptibility to Mitoxantrone]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [ERBB2 results in decreased susceptibility to Mitoxantrone]; [ERBB2 results in increased expression of ABCG2] which results in decreased susceptibility to Mitoxantrone; ABCG2 mutant form inhibits the reaction [ERBB2 results in decreased susceptibility to Mitoxantrone] |
CTD |
PMID:21712253 |
|
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
|
|
G |
Erbb3 |
erb-b2 receptor tyrosine kinase 3 |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of ERBB3 mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr 7:994,549...1,015,876
Ensembl chr 7:996,225...1,015,525
|
|
G |
Etfdh |
electron transfer flavoprotein dehydrogenase |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of ETFDH protein |
CTD |
PMID:34246718 |
|
NCBI chr 2:164,740,547...164,762,754
Ensembl chr 2:164,729,749...164,762,745
|
|
G |
Evi5 |
ecotropic viral integration site 5 |
affects response to substance |
ISO |
EVI5 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr14:1,875,601...2,021,678
Ensembl chr14:1,875,647...2,021,678
|
|
G |
Extl2 |
exostosin-like glycosyltransferase 2 |
affects response to substance |
ISO |
EXTL2 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 2:203,922,217...203,946,940
Ensembl chr 2:203,922,187...203,943,653
|
|
G |
Fabp3 |
fatty acid binding protein 3 |
increases expression |
EXP |
Mitoxantrone results in increased expression of FABP3 protein |
CTD |
PMID:22878004 |
|
NCBI chr 5:142,651,962...142,658,707
Ensembl chr 5:142,651,956...142,658,718
|
|
G |
Fam117a |
family with sequence similarity 117, member A |
affects response to substance |
ISO |
FAM117A protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr10:80,281,411...80,325,345
Ensembl chr10:80,281,408...80,325,343
|
|
G |
Fas |
Fas cell surface death receptor |
multiple interactions increases expression |
ISO |
Hydrocortisone promotes the reaction [Mitoxantrone results in increased expression of FAS] Mitoxantrone results in increased expression of FAS mRNA; Mitoxantrone results in increased expression of FAS protein |
CTD |
PMID:9676859 PMID:26537877 PMID:28940058 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Fasn |
fatty acid synthase |
decreases response to substance multiple interactions |
ISO |
FASN protein results in decreased susceptibility to Mitoxantrone orlistat inhibits the reaction [FASN protein results in decreased susceptibility to Mitoxantrone] |
CTD |
PMID:18281512 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fdft1 |
farnesyl diphosphate farnesyl transferase 1 |
affects response to substance |
ISO |
FDFT1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr15:37,412,143...37,440,198
Ensembl chr15:37,412,146...37,440,287
|
|
G |
Fhl1 |
four and a half LIM domains 1 |
increases expression |
EXP |
Mitoxantrone results in increased expression of FHL1 mRNA |
CTD |
PMID:23558518 |
|
NCBI chr X:134,555,399...134,614,930
Ensembl chr X:134,555,479...134,614,928
|
|
G |
Flrt3 |
fibronectin leucine rich transmembrane protein 3 |
affects response to substance |
ISO |
FLRT3 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 3:127,994,491...128,008,137
Ensembl chr 3:127,994,226...128,007,841
|
|
G |
Fndc3a |
fibronectin type III domain containing 3a |
affects response to substance |
ISO |
FNDC3A protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr15:47,689,909...47,867,354
Ensembl chr15:47,689,919...47,866,784
|
|
G |
Foxf2 |
forkhead box F2 |
affects response to substance |
ISO |
FOXF2 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr17:32,835,730...32,842,547
Ensembl chr17:32,836,777...32,842,176
|
|
G |
Fyn |
FYN proto-oncogene, Src family tyrosine kinase |
affects response to substance |
ISO |
FYN protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr20:42,767,733...42,960,903
Ensembl chr20:42,766,369...42,959,911
|
|
G |
Fzd2 |
frizzled class receptor 2 |
affects response to substance |
ISO |
FZD2 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr10:87,561,866...87,563,776
Ensembl chr10:87,561,326...87,565,334
|
|
G |
Gch1 |
GTP cyclohydrolase 1 |
affects response to substance |
ISO |
GCH1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr15:20,404,267...20,437,727
Ensembl chr15:20,402,527...20,437,698
|
|
G |
Gdf15 |
growth differentiation factor 15 |
increases expression |
ISO |
Mitoxantrone results in increased expression of GDF15 mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
|
|
G |
Glul |
glutamate-ammonia ligase |
affects response to substance |
ISO |
GLUL protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr13:65,969,053...66,035,121
Ensembl chr13:66,025,630...66,035,108
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
increases expression |
ISO |
Mitoxantrone results in increased expression of GPX1 mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
affects response to substance |
ISO |
GPX3 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
|
|
G |
Gucy1b1 |
guanylate cyclase 1 soluble subunit beta 1 |
affects response to substance |
ISO |
GUCY1B1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 2:167,348,824...167,398,983
Ensembl chr 2:167,348,825...167,398,916
|
|
G |
H2ax |
H2A.X variant histone |
increases expression increases phosphorylation multiple interactions |
ISO EXP |
Mitoxantrone results in increased expression of H2AX protein Mitoxantrone results in increased phosphorylation of H2AX protein Poly(ADP-ribose) Polymerase Inhibitors affects the reaction [Mitoxantrone results in increased expression of H2AX protein] |
CTD |
PMID:19738048 PMID:24994473 PMID:29913208 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
|
|
G |
Hadhb |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of HADHB protein |
CTD |
PMID:34246718 |
|
NCBI chr 6:26,153,572...26,187,668
Ensembl chr 6:26,153,578...26,184,869
|
|
G |
Hdac4 |
histone deacetylase 4 |
affects response to substance |
ISO |
HDAC4 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 9:92,503,467...92,750,164
Ensembl chr 9:92,507,611...92,750,164
|
|
G |
Hmg20b |
high mobility group 20 B |
affects response to substance |
ISO |
HMG20B protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 7:8,368,934...8,373,650
Ensembl chr 7:8,368,990...8,373,640
|
|
G |
Hoxa5 |
homeo box A5 |
affects response to substance |
ISO |
HOXA5 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 4:81,302,341...81,306,234
Ensembl chr 4:81,302,353...81,306,234
|
|
G |
Hrc |
histidine rich calcium binding protein |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of HRC mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr 1:95,813,262...95,816,987
Ensembl chr 1:95,813,253...95,816,984
|
|
G |
Hspa2 |
heat shock protein family A (Hsp70) member 2 |
affects response to substance |
ISO |
HSPA2 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 6:95,128,504...95,131,281
Ensembl chr 6:95,128,350...95,131,287
|
|
G |
Idh3a |
isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha |
affects response to substance decreases expression |
ISO |
IDH3A protein affects the susceptibility to Mitoxantrone Mitoxantrone results in decreased expression of IDH3A protein |
CTD |
PMID:16217747 PMID:34246718 |
|
NCBI chr 8:54,971,694...54,991,085
Ensembl chr 8:54,971,740...54,991,084
|
|
G |
Ifitm1 |
interferon induced transmembrane protein 1 |
affects response to substance |
ISO |
IFITM1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 1:196,067,163...196,069,169
Ensembl chr 1:196,067,963...196,069,169
|
|
G |
Igf1r |
insulin-like growth factor 1 receptor |
affects response to substance |
ISO |
IGF1R protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:15499378 |
|
NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777
|
|
G |
Igf2bp3 |
insulin-like growth factor 2 mRNA binding protein 3 |
affects response to substance |
ISO |
IGF2BP3 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 4:78,060,494...78,195,007
Ensembl chr 4:78,060,494...78,194,865
|
|
G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
affects response to substance |
ISO |
IGFBP3 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083
|
|
G |
Igfbp7 |
insulin-like growth factor binding protein 7 |
affects response to substance |
ISO |
IGFBP7 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr14:30,737,414...30,797,317
Ensembl chr14:30,737,164...30,797,314
|
|
G |
Il13ra2 |
interleukin 13 receptor subunit alpha 2 |
affects response to substance |
ISO |
IL13RA2 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr X:111,002,590...111,074,053
Ensembl chr X:111,002,592...111,072,381
|
|
G |
Immt |
inner membrane mitochondrial protein |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of IMMT protein |
CTD |
PMID:34246718 |
|
NCBI chr 4:103,880,482...103,919,116
Ensembl chr 4:103,880,459...103,919,109
|
|
G |
Iqgap1 |
IQ motif containing GTPase activating protein 1 |
affects response to substance |
ISO |
IQGAP1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 1:134,679,581...134,769,776
Ensembl chr 1:134,679,586...134,769,755
|
|
G |
Irf7 |
interferon regulatory factor 7 |
affects response to substance |
ISO |
IRF7 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 1:196,367,380...196,370,943
Ensembl chr 1:196,367,361...196,370,832
|
|
G |
Irx1 |
iroquois homeobox 1 |
affects response to substance |
ISO |
IRX1 mRNA affects the susceptibility to Mitoxantrone |
CTD |
PMID:16044152 |
|
NCBI chr 1:31,294,615...31,300,444
Ensembl chr 1:31,294,615...31,300,444
|
|
G |
Irx4 |
iroquois homeobox 4 |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of IRX4 mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr 1:30,030,561...30,039,549
Ensembl chr 1:30,030,561...30,039,549
|
|
G |
Isg15 |
ISG15 ubiquitin-like modifier |
affects response to substance |
ISO |
ISG15 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 5:166,784,148...166,785,435
Ensembl chr 5:166,784,148...166,785,435
|
|
G |
Isg20 |
interferon stimulated exonuclease gene 20 |
affects response to substance |
ISO |
ISG20 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 1:132,829,303...132,837,027
Ensembl chr 1:132,815,123...132,837,027
|
|
G |
Jak2 |
Janus kinase 2 |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of JAK2 mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions increases expression |
ISO |
Tetradecanoylphorbol Acetate promotes the reaction [Mitoxantrone results in increased expression of JUN mRNA] |
CTD |
PMID:8219202 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Kcnab2 |
potassium voltage-gated channel subfamily A regulatory beta subunit 2 |
affects response to substance |
ISO |
KCNAB2 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 5:162,899,511...162,988,057
Ensembl chr 5:162,901,896...162,988,243
|
|
G |
Kcnh2 |
potassium voltage-gated channel subfamily H member 2 |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of KCNH2 mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
|
|
G |
Kcnj2 |
potassium inwardly-rectifying channel, subfamily J, member 2 |
increases expression |
ISO |
Mitoxantrone results in increased expression of KCNJ2 mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr10:96,060,834...96,071,397
Ensembl chr10:96,060,821...96,071,445
|
|
G |
Kcnq1 |
potassium voltage-gated channel subfamily Q member 1 |
decreases expression |
ISO |
Mitoxantrone results in decreased expression of KCNQ1 mRNA |
CTD |
PMID:26537877 PMID:28940058 |
|
NCBI chr 1:198,291,711...198,624,683
Ensembl chr 1:198,291,766...198,624,669
|
|
G |
Krr1 |
KRR1, small subunit processome component homolog |
affects response to substance |
ISO |
KRR1 protein affects the susceptibility to Mitoxantrone |
CTD |
PMID:16217747 |
|
NCBI chr 7:47,475,557...47,486,996
Ensembl chr 7:47,475,557...47,486,985
|
|
G |
Lama2 |
laminin subunit alpha 2 |
affects r | |